vignette,question_1,question_2,question_3,question_4,question_5,answer_1,answer_2,answer_3,answer_4,answer_5,marks_1,marks_2,marks_3,marks_4,marks_5,Total_Marks_Achieved
" History of Present Illness
A 58-year-old male presents with a 3-week history of gradually worsening fatigue, weight loss, and fever. Over the past week, he has developed pain and redness in his right hand, which has been intermittently swollen. He denies trauma or any recent infections. He also reports having had bilateral leg pain that worsens with activity but improves with rest. The patient has no history of similar symptoms. He has not been on any new medications, and he denies smoking or alcohol use. His family history is notable for autoimmune diseases, as his father has rheumatoid arthritis. 

  Past Medical History
The patient has a history of hypertension for 10 years, managed with an ACE inhibitor. He has no known history of autoimmune diseases or vasculitis. He underwent a cholecystectomy 5 years ago . 

  Physical Examination
VITALS: BP 135/85 mmHg, pulse 88 bpm, temperature 100.4°F. 
GEN: Ill-appearing, mildly febrile, visibly fatigued. 
CARDIAC: Regular rhythm, no murmurs, Feeble peripheral pulses 
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender, no hepatosplenomegaly. 
MSK: Swelling and erythema of the right hand with tenderness to palpation at the metacarpophalangeal joint. Bilateral calf tenderness with no signs of deep venous thrombosis. 
EXT: No edema, but marked tenderness in the lower extremities. 
SKIN: Petechial rash over the anterior shin. 

  Laboratory Results
WBC: 12 x 103 cells/μL (elevated). Hemoglobin: 11.8 g/dL. ESR: 65 mm/h (elevated). Positive anti-ds DNA antibodies. CRP: 45 mg/L (elevated). Urinalysis: 2+ protein, no blood. Creatinine: 1.2 mg/dL.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Systemic Lupus Erythematosus (SLE)**: The presence of anti-dsDNA antibodies, elevated ESR, and CRP, along with symptoms such as fatigue, fever, weight loss, and joint pain, suggest SLE as a possible diagnosis. The patient's family history of autoimmune diseases also supports this possibility.
2. **Rheumatoid Arthritis (RA)**: The patient's symptoms of joint pain and swelling, particularly in the hands and feet, along with elevated inflammatory markers (ESR and CRP), could suggest RA. The patient's father has a history of RA, which increases the likelihood of this diagnosis.
3. **Vasculitis (e.g., Polyarteritis Nodosa or Giant Cell Arteritis)**: The patient's symptoms of fever, weight loss, and fatigue, along with the presence of a petechial rash and tenderness in the lower extremities, could suggest a vasculitic process. The elevated WBC and inflammatory markers also support this possibility.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Systemic Lupus Erythematosus (SLE)**

* **Positive anti-dsDNA antibodies**: A specific and sensitive marker for SLE
* **Elevated ESR (65 mm/h) and CRP (45 mg/L)**: Indicative of active inflammation, which is a hallmark of SLE
* **Proteinuria (2+ protein on urinalysis)**: Suggests renal involvement, which is common in SLE
* **Family history of autoimmune diseases (father with rheumatoid arthritis)**: Increases the likelihood of developing an autoimmune disease like SLE
* **Systemic symptoms (fatigue, weight loss, fever)**: Common in SLE, which can affect multiple organ systems
* **Joint pain and swelling (particularly in the hands)**: A common manifestation of SLE

**2. Rheumatoid Arthritis (RA)**

* **Joint pain and swelling (particularly in the hands)**: A hallmark of RA, which typically affects the small joints of the hands and feet
* **Morning stiffness and tenderness**: Although not explicitly mentioned, the patient's symptoms of joint pain and swelling suggest the possibility of morning stiffness and tenderness, which are common in RA
* **Elevated ESR (65 mm/h) and CRP (45 mg/L)**: Indicative of active inflammation, which is a key feature of RA
* **Family history of RA (father with RA)**: Increases the likelihood of developing RA
* **Bilateral calf tenderness**: Could be related to enthesitis or tendonitis, which can occur in RA

**3. Vasculitis (e.g., Polyarteritis Nodosa or Giant Cell Arteritis)**

* **Systemic symptoms (fatigue, weight loss, fever)**: Common in vasculitis, which can affect multiple organ systems
* **Petechial rash**: A possible manifestation of vasculitis, which can cause skin lesions and rashes
* **Tenderness in the lower extremities**: Could be related to vasculitic involvement of the blood vessels in the legs
* **Elevated WBC (12 x 10^3 cells/μL)**: Suggests an inflammatory or infectious process, which can occur in vasculitis
* **Feeble peripheral pulses**: Could indicate vascular involvement or vasculitis, which can affect blood flow to the extremities
* **Age and sex**: The patient's age (58) and sex (male) are consistent with the demographics of some types of vasculitis, such as Polyarteritis Nodosa.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Systemic Lupus Erythematosus (SLE)**

* **Lack of specific skin manifestations**: While the patient has a petechial rash, there is no mention of a characteristic SLE rash, such as a malar rash or discoid rash.
* **No mention of oral ulcers or hair loss**: These are common symptoms of SLE, but they are not reported in this patient.
* **Normal urinalysis for blood**: While the patient has proteinuria, the lack of hematuria (blood in the urine) is somewhat unexpected in SLE, which can cause renal inflammation and damage.
* **No mention of neurological or psychiatric symptoms**: SLE can affect the nervous system, causing symptoms such as seizures, psychosis, or cognitive impairment, but these are not reported in this patient.
* **Hemoglobin level is only mildly decreased (11.8 g/dL)**: While anemia is common in SLE, the patient's hemoglobin level is not severely decreased, which might suggest a milder disease course or a different diagnosis.

**2. Rheumatoid Arthritis (RA)**

* **Lack of morning stiffness**: While the patient has joint pain and swelling, there is no mention of morning stiffness, which is a characteristic symptom of RA.
* **No mention of symmetric joint involvement**: RA typically affects joints in a symmetric pattern, but the patient's symptoms are not clearly symmetric.
* **Presence of systemic symptoms (fever, weight loss)**: While RA can cause systemic symptoms, they are not as common as in other diagnoses, such as SLE or vasculitis.
* **Elevated WBC (12 x 10^3 cells/μL)**: While RA can cause an elevated WBC, this is not a typical finding in RA, and other diagnoses, such as infection or vasculitis, might be more likely to cause leukocytosis.
* **No mention of rheumatoid nodules**: These are a characteristic finding in RA, but they are not reported in this patient.

**3. Vasculitis (e.g., Polyarteritis Nodosa or Giant Cell Arteritis)**

* **Lack of specific organ involvement**: While the patient has systemic symptoms and a petechial rash, there is no clear evidence of organ-specific involvement, such as kidney or lung disease, which is often seen in vasculitis.
* **No mention of neuropathic symptoms**: Vasculitis can cause neuropathy, but the patient does not report any symptoms such as numbness, tingling, or weakness.
* **Normal pulmonary examination**: Vasculitis can affect the lungs, causing symptoms such as cough or shortness of breath, but the patient's pulmonary examination is normal.
* **No mention of abdominal pain or gastrointestinal symptoms**: Vasculitis can cause abdominal pain, gastrointestinal bleeding, or other symptoms, but these are not reported in this patient.
* **Elevated anti-dsDNA antibodies**: This is not a typical finding in vasculitis, and the presence of these antibodies might suggest a different diagnosis, such as SLE.","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Systemic Lupus Erythematosus (SLE)**

The patient's presentation with systemic symptoms (fatigue, weight loss, fever), joint pain and swelling, and a petechial rash, along with the presence of positive anti-dsDNA antibodies, elevated ESR and CRP, and proteinuria, are all consistent with a diagnosis of SLE.

The patient's family history of autoimmune diseases, including his father's rheumatoid arthritis, also increases the likelihood of developing an autoimmune disease like SLE.

While the patient's symptoms and laboratory results could also be consistent with other diagnoses, such as rheumatoid arthritis or vasculitis, the presence of positive anti-dsDNA antibodies and the patient's overall clinical presentation are most consistent with a diagnosis of SLE.

**Classification criteria:**

The patient meets the 1997 American College of Rheumatology (ACR) classification criteria for SLE, which include:

* 4 or more of the following criteria:
	+ Malar rash
	+ Discoid rash
	+ Photosensitivity
	+ Oral ulcers
	+ Arthritis (non-erosive)
	+ Serositis (pleuritis or pericarditis)
	+ Kidney disorder (persistent proteinuria or cellular casts)
	+ Neurological disorder (seizures or psychosis)
	+ Hematologic disorder (hemolytic anemia, leukopenia, or lymphopenia)
	+ Immunological disorder (anti-DNA, anti-Sm, or antiphospholipid antibodies)
	+ Antinuclear antibodies (ANA)

The patient meets at least 4 of these criteria, including:

* Arthritis (non-erosive)
* Kidney disorder (proteinuria)
* Hematologic disorder (mild anemia)
* Immunological disorder (anti-dsDNA antibodies)
* Antinuclear antibodies (ANA) (not explicitly stated, but likely present given the patient's positive anti-dsDNA antibodies)

**Next steps:**

The patient should be referred to a rheumatologist for further evaluation and management. Treatment may include:

* Corticosteroids to reduce inflammation and suppress the immune system
* Immunosuppressive medications to reduce the risk of organ damage
* Anti-malarial medications to reduce the risk of flares and improve symptoms
* Close monitoring of kidney function, blood counts, and other laboratory tests to assess disease activity and response to treatment.","Based on the diagnosis of Systemic Lupus Erythematosus (SLE), the following additional steps should be taken:

**Immediate steps:**

1. **Initiate corticosteroid therapy**: Start the patient on a moderate to high dose of corticosteroids (e.g., prednisone 20-40 mg/day) to reduce inflammation and suppress the immune system.
2. **Order additional laboratory tests**: Include:
	* Complete Blood Count (CBC) with differential to assess for anemia, leukopenia, or thrombocytopenia.
	* Blood chemistry tests (e.g., liver function tests, electrolyte panel) to assess for organ damage.
	* Urine tests (e.g., urine protein-to-creatinine ratio) to assess for kidney damage.
	* Coagulation studies (e.g., prothrombin time, partial thromboplastin time) to assess for bleeding disorders.
3. **Assess for organ damage**: Evaluate the patient for signs of organ damage, such as:
	* Kidney damage: assess for proteinuria, hematuria, or elevated creatinine levels.
	* Lung damage: assess for shortness of breath, cough, or chest pain.
	* Cardiac damage: assess for chest pain, shortness of breath, or abnormal electrocardiogram (ECG) findings.
	* Neurological damage: assess for seizures, psychosis, or cognitive impairment.

**Short-term steps:**

1. **Refer to a rheumatologist**: Schedule an appointment with a rheumatologist to confirm the diagnosis and develop a long-term treatment plan.
2. **Initiate immunosuppressive therapy**: Consider adding immunosuppressive medications (e.g., hydroxychloroquine, azathioprine) to reduce the risk of organ damage and improve symptoms.
3. **Monitor for infection**: SLE patients are at increased risk of infection, so monitor for signs of infection (e.g., fever, chills, cough) and treat promptly if necessary.
4. **Assess for osteoporosis**: SLE patients are at increased risk of osteoporosis due to corticosteroid therapy, so assess for osteoporosis and consider preventive measures (e.g., calcium and vitamin D supplements).

**Long-term steps:**

1. **Develop a treatment plan**: Work with the patient to develop a comprehensive treatment plan that includes medication, lifestyle modifications, and regular monitoring.
2. **Monitor disease activity**: Regularly assess disease activity using measures such as the SLE Disease Activity Index (SLEDAI) or the British Isles Lupus Assessment Group (BILAG) index.
3. **Adjust treatment as needed**: Adjust the treatment plan as needed to achieve and maintain remission, and to minimize side effects.
4. **Provide patient education**: Educate the patient on SLE, its symptoms, and its treatment, and provide resources for support and advocacy.

**Additional considerations:**

1. **Pregnancy planning**: If the patient is a woman of childbearing age, discuss pregnancy planning and the risks associated with SLE during pregnancy.
2. **Vaccinations**: Consider vaccinating the patient against influenza and pneumococcus to reduce the risk of infection.
3. **Mental health support**: Offer mental health support and resources to help the patient cope with the emotional and psychological aspects of SLE.","{""Score"":3,""Rationale"":""The answer includes Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), and Vasculitis (Polyarteritis Nodosa), all of which match items listed in the high‑scoring example.""}","{""Score"":6,""Rationale"":""Student listed the key concepts for SLE (anti‑dsDNA, fatigue/weight loss/fever, elevated ESR/CRP, hand pain/swelling, family history), for RA (hand swelling/tenderness, family history, inflammatory markers) and for Vasculitis (fever, weight loss, petechial rash, proteinuria). These match the high‑scoring example concepts, earning full points. No concepts for Peripheral Vascular Disease were provided, but the rubric awards points per diagnosis and the three required diagnoses were fully covered.""}","{""Score"":6,""Rationale"":""The answer includes the required opposing findings for Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Vasculitis that match the high‑scoring example; therefore all three 2‑point items are satisfied.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Systemic Lupus Erythematosus (SLE) and cites the same key clinical findings (fever, weight loss, elevated ESR/CRP, arthritis, rash, proteinuria) as in the high‑scoring example, thus meeting the rubric criteria for full credit.""}","{""Score"":4,""Rationale"":""The answer includes referral to a rheumatologist and initiation of hydroxychloroquine, matching two rubric items (2 points each). It does not mention performing a kidney biopsy, so that item receives no points.""}",21.0
"History of Present Illness 
A 58-year-old male presents with a 6-month history of progressive fatigue, weight loss, and peripheral edema. He also reports shortness of breath on exertion and difficulty swallowing solid foods for the past 2 months. His urine has become frothy, and he has noticed some tingling sensations in his hands. He denies chest pain, fever, or night sweats. There is no history of hypertension, diabetes, or known heart disease. 
Past Medical History 
The patient has a 10-year history of rheumatoid arthritis, well-controlled with methotrexate. He denies smoking or alcohol use. Family history is negative for any genetic disorders. 
Physical Examination 
VITALS: BP 110/70 mmHg, pulse 90/min, temperature 98.4°F. 
GEN: Thin, pale, fatigued. 
CARDIAC: No murmurs, but there is a slight periorbital edema. 
PULM: Clear to auscultation bilaterally. 
ABD: Mild hepatomegaly (2 cm below the costal margin), no tenderness. 
EXT: Bilateral pedal edema, no erythema or ulcers. 
NEURO: Decreased sensation to light touch in both feet, absent ankle reflexes. 

Laboratory Results
Urinalysis shows 2+ proteinuria, and serum creatinine is 1.5 mg/dL. The BNP is elevated at 550 pg/mL. Serum free light chains are elevated, and a biopsy of abdominal fat reveals amyloid deposits. Echocardiogram shows concentric left ventricular hypertrophy with normal systolic function. Hemoglobin levels within normal range.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Amyloidosis**: The presence of amyloid deposits in the abdominal fat biopsy, elevated serum free light chains, and proteinuria suggest amyloidosis, a condition characterized by the deposition of abnormal proteins (amyloid) in various tissues and organs.
2. **Cardiac Amyloidosis**: The patient's symptoms of shortness of breath, peripheral edema, and elevated BNP, combined with the echocardiogram findings of concentric left ventricular hypertrophy, suggest cardiac involvement, which is consistent with cardiac amyloidosis.
3. **Light-Chain (AL) Amyloidosis**: The elevation of serum free light chains and the presence of amyloid deposits in the abdominal fat biopsy suggest light-chain (AL) amyloidosis, a type of amyloidosis associated with the production of abnormal light-chain proteins, often in the context of a plasma cell dyscrasia, such as multiple myeloma or Waldenström's macroglobulinemia.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Amyloidosis**

* **Abdominal fat biopsy showing amyloid deposits**: This is a definitive diagnostic finding for amyloidosis.
* **Elevated serum free light chains**: This suggests the presence of a plasma cell dyscrasia, which is a common cause of amyloidosis.
* **Proteinuria (2+ on urinalysis)**: Amyloidosis can cause kidney damage, leading to proteinuria.
* **Peripheral edema and weight loss**: These are common symptoms of amyloidosis, particularly in advanced cases.
* **History of rheumatoid arthritis**: Some forms of amyloidosis, such as AA amyloidosis, are associated with chronic inflammatory diseases like rheumatoid arthritis.

**2. Cardiac Amyloidosis**

* **Elevated BNP (550 pg/mL)**: This suggests cardiac dysfunction, which is consistent with cardiac amyloidosis.
* **Concentric left ventricular hypertrophy on echocardiogram**: This is a characteristic finding in cardiac amyloidosis.
* **Shortness of breath on exertion**: This is a common symptom of cardiac amyloidosis, due to impaired cardiac function.
* **Periorbital edema**: This can be a sign of cardiac amyloidosis, particularly in the context of other cardiac symptoms.
* **Absence of hypertension or known heart disease**: Cardiac amyloidosis can cause cardiac dysfunction in the absence of traditional cardiovascular risk factors.

**3. Light-Chain (AL) Amyloidosis**

* **Elevated serum free light chains**: This is a hallmark of light-chain amyloidosis, which is caused by the production of abnormal light-chain proteins.
* **Abdominal fat biopsy showing amyloid deposits**: This confirms the presence of amyloidosis, and the elevation of serum free light chains suggests a light-chain origin.
* **History of rheumatoid arthritis**: While not directly related to light-chain amyloidosis, the patient's history of rheumatoid arthritis may increase the risk of developing a plasma cell dyscrasia, such as multiple myeloma, which can cause light-chain amyloidosis.
* **Age and sex of the patient**: Light-chain amyloidosis is more common in older adults, and men are more frequently affected than women.
* **Progressive fatigue, weight loss, and peripheral edema**: These are common symptoms of light-chain amyloidosis, particularly in advanced cases.","Here are the findings that oppose or do not support each of the possible diagnoses:

**1. Amyloidosis**

* **Normal hemoglobin levels**: Amyloidosis can cause anemia, but the patient's hemoglobin levels are within normal range.
* **Absence of macroglossia**: Macroglossia (enlarged tongue) is a common symptom of amyloidosis, but it is not mentioned in the patient's physical examination.
* **No history of carpal tunnel syndrome**: Carpal tunnel syndrome is a common symptom of amyloidosis, particularly in patients with wild-type transthyretin amyloidosis, but it is not mentioned in the patient's history.
* **Mild hepatomegaly (only 2 cm below the costal margin)**: While hepatomegaly can occur in amyloidosis, the degree of hepatomegaly in this patient is relatively mild, which may suggest a less severe disease process.
* **No mention of gastrointestinal symptoms**: Amyloidosis can cause gastrointestinal symptoms such as diarrhea, constipation, or abdominal pain, but these are not mentioned in the patient's history.

**2. Cardiac Amyloidosis**

* **Normal systolic function on echocardiogram**: Cardiac amyloidosis often causes impaired systolic function, but the patient's echocardiogram shows normal systolic function.
* **No murmurs on cardiac examination**: Cardiac amyloidosis can cause murmurs due to valvular dysfunction, but none are mentioned in the patient's physical examination.
* **BP 110/70 mmHg**: Cardiac amyloidosis can cause hypotension, particularly in advanced cases, but the patient's blood pressure is within normal range.
* **No signs of congestive heart failure**: While the patient has peripheral edema, there are no other signs of congestive heart failure, such as pulmonary edema or jugular venous distension.
* **Elevated BNP, but not extremely high**: While the patient's BNP is elevated, it is not extremely high, which may suggest a less severe degree of cardiac dysfunction.

**3. Light-Chain (AL) Amyloidosis**

* **No mention of bone pain or lytic lesions**: Light-chain amyloidosis is often associated with multiple myeloma, which can cause bone pain or lytic lesions, but these are not mentioned in the patient's history.
* **No anemia**: Anemia is a common symptom of multiple myeloma and light-chain amyloidosis, but the patient's hemoglobin levels are within normal range.
* **No hypercalcemia**: Hypercalcemia is a common symptom of multiple myeloma, but the patient's calcium levels are not mentioned, and there is no other indication of hypercalcemia.
* **No mention of renal failure**: While the patient has proteinuria, there is no mention of renal failure or significantly elevated serum creatinine levels, which can occur in light-chain amyloidosis.
* **Patient's age and sex are not strongly suggestive of multiple myeloma**: While the patient is 58 years old, which is within the age range for multiple myeloma, the incidence of multiple myeloma increases with age, and the patient is not extremely old. Additionally, men are more frequently affected than women, but the patient's sex is not strongly suggestive of multiple myeloma.","Based on the patient's symptoms, physical examination, laboratory results, and biopsy findings, the final diagnosis is:

**Light-Chain (AL) Amyloidosis**

The key findings that support this diagnosis include:

* **Elevated serum free light chains**: This suggests the presence of a plasma cell dyscrasia, which is a common cause of light-chain amyloidosis.
* **Abdominal fat biopsy showing amyloid deposits**: This confirms the presence of amyloidosis, and the elevation of serum free light chains suggests a light-chain origin.
* **Proteinuria (2+ on urinalysis)**: This suggests kidney damage, which is a common complication of light-chain amyloidosis.
* **Peripheral edema and weight loss**: These are common symptoms of light-chain amyloidosis, particularly in advanced cases.
* **Shortness of breath on exertion and difficulty swallowing solid foods**: These symptoms suggest cardiac and gastrointestinal involvement, which are common in light-chain amyloidosis.
* **Elevated BNP (550 pg/mL)**: This suggests cardiac dysfunction, which is consistent with cardiac amyloidosis, a common complication of light-chain amyloidosis.
* **Concentric left ventricular hypertrophy on echocardiogram**: This is a characteristic finding in cardiac amyloidosis, which is often associated with light-chain amyloidosis.

While the patient's history of rheumatoid arthritis could suggest AA amyloidosis, the elevation of serum free light chains and the presence of amyloid deposits in the abdominal fat biopsy are more consistent with light-chain amyloidosis. Additionally, the patient's symptoms and laboratory results are not typical of other forms of amyloidosis, such as wild-type transthyretin amyloidosis or hereditary amyloidosis.

**Recommendations for further evaluation and management:**

* **Bone marrow biopsy**: To evaluate for multiple myeloma or other plasma cell dyscrasias.
* **Imaging studies**: To evaluate for lytic lesions or other signs of multiple myeloma.
* **Cardiac evaluation**: To further evaluate the extent of cardiac involvement and to guide management.
* **Nephrology consultation**: To manage the patient's proteinuria and to evaluate for renal failure.
* **Hematology consultation**: To guide management of the patient's plasma cell dyscrasia and to consider treatment options such as chemotherapy or stem cell transplantation.","Based on the final diagnosis of Light-Chain (AL) Amyloidosis, the following additional steps can be taken:

**Diagnostic Steps:**

1. **Bone marrow biopsy**: To confirm the presence of a plasma cell dyscrasia, such as multiple myeloma, and to evaluate the extent of bone marrow involvement.
2. **Immunofixation electrophoresis (IFE)**: To identify the specific type of light chain (kappa or lambda) and to evaluate for the presence of monoclonal proteins.
3. **Serum protein electrophoresis (SPEP)**: To evaluate for the presence of monoclonal proteins and to monitor the patient's response to treatment.
4. **Urinary protein electrophoresis (UPEP)**: To evaluate for the presence of Bence-Jones proteins (free light chains) in the urine.
5. **Cardiac MRI**: To further evaluate the extent of cardiac involvement and to guide management.
6. **Nerve conduction studies (NCS) and electromyography (EMG)**: To evaluate for the presence of peripheral neuropathy, which is a common complication of light-chain amyloidosis.

**Therapeutic Steps:**

1. **Chemotherapy**: To treat the underlying plasma cell dyscrasia, such as multiple myeloma, and to reduce the production of light chains.
2. **Autologous stem cell transplantation (ASCT)**: To consolidate the patient's response to chemotherapy and to improve long-term outcomes.
3. **Supportive care**: To manage the patient's symptoms, such as pain, fatigue, and shortness of breath, and to improve quality of life.
4. **Dialysis**: To manage the patient's renal failure, if present, and to improve electrolyte imbalances.
5. **Cardiac medications**: To manage the patient's cardiac symptoms, such as heart failure, and to improve cardiac function.
6. **Pain management**: To manage the patient's pain, which can be a significant symptom of light-chain amyloidosis.

**Monitoring Steps:**

1. **Regular serum free light chain (SFLC) measurements**: To monitor the patient's response to treatment and to adjust the treatment plan as needed.
2. **Regular urine protein measurements**: To monitor the patient's renal function and to adjust the treatment plan as needed.
3. **Regular cardiac evaluations**: To monitor the patient's cardiac function and to adjust the treatment plan as needed.
4. **Regular nerve conduction studies (NCS) and electromyography (EMG)**: To monitor the patient's peripheral neuropathy and to adjust the treatment plan as needed.
5. **Regular bone marrow biopsies**: To monitor the patient's bone marrow involvement and to adjust the treatment plan as needed.

**Multidisciplinary Care:**

1. **Hematology consultation**: To guide management of the patient's plasma cell dyscrasia and to consider treatment options such as chemotherapy or stem cell transplantation.
2. **Cardiology consultation**: To guide management of the patient's cardiac symptoms and to consider treatment options such as cardiac medications or cardiac transplantation.
3. **Nephrology consultation**: To guide management of the patient's renal failure and to consider treatment options such as dialysis or renal transplantation.
4. **Neurology consultation**: To guide management of the patient's peripheral neuropathy and to consider treatment options such as pain management or physical therapy.
5. **Palliative care consultation**: To guide management of the patient's symptoms and to improve quality of life.","{""Score"":1,""Rationale"":""The answer includes Amyloidosis, which matches a high‑scoring item in the rubric (1 mark). It does not include Congestive Cardiac Failure, Chronic Kidney Disease, or Multiple Myeloma, so no additional points are awarded.""}","{""Score"":2,""Rationale"":""The answer includes the key points for Amyloidosis as listed in the rubric, earning 2 points. It does not explicitly address Congestive Cardiac Failure, Chronic Kidney Disease, or Multiple Myeloma as required by the rubric, so no points are awarded for those sections.""}","{""Score"":0,""Rationale"":""The answer does not contain any of the specific opposing findings or concepts listed in the high‑scoring rubric for Amyloidosis, Congestive Cardiac Failure, CKD, or amyloid deposition on biopsy with multiple myeloma, so no points are awarded.""}","{""Score"":2,""Rationale"":""Student correctly identified amyloidosis with supporting edema, proteinuria, and biopsy confirming amyloid deposits, matching the high‑scoring example.""}","{""Score"":4,""Rationale"":""The answer includes Bone marrow biopsy and Cardiac MRI, matching two of the three rubric items (each 2 points). It does not mention Renal biopsy, so no points for that item.""}",9.0
"History of Present Illness
A 59-year-old male presents with swelling and pain in his right leg that started 3 days ago. He was discharged from the hospital 2 weeks ago after undergoing knee replacement surgery, during which he received prophylactic low molecular weight heparin. He reports intermittent fever and recent episodes of palpitations. He denies chest pain, shortness of breath, or prior deep vein thrombosis (DVT). 

  Past Medical History
He has a history of osteoarthritis requiring knee replacement. He has hypertension, controlled with amlodipine, and a history of dyslipidemia. He has no history of malignancy or clotting disorders. 

  Physical Examination
VITALS: BP 125/80 mmHg, pulse 102/min, temperature 99.6°F. 
GEN: Appears mildly uncomfortable. 
CARDIAC: Regular rhythm, no murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender. 
EXT: Right leg swollen with mild erythema and tenderness along the femoral vein. Homans' sign is positive. No ulcers or skin changes. 
SKIN: Petechiae on both forearms. 

  Laboratory Results
Platelet count has decreased to 58 x 10³/μL from 210 x 10³/μL 10 days ago. D-dimer is elevated at 5.2 μg/mL. The Heparin-PF4 antibody test is positive. Ultrasound reveals a thrombus in the right femoral vein.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Heparin-Induced Thrombocytopenia (HIT)**: The patient has a history of recent heparin use, a significant drop in platelet count, and a positive Heparin-PF4 antibody test, which are all consistent with HIT.
2. **Deep Vein Thrombosis (DVT)**: The patient presents with swelling, pain, and erythema in the right leg, and ultrasound confirms a thrombus in the right femoral vein, which is consistent with DVT.
3. **Thromboembolic Disease with Immune-Mediated Thrombocytopenia**: The patient's symptoms, including palpitations, intermittent fever, and petechiae, along with the laboratory findings of thrombocytopenia and elevated D-dimer, could suggest a thromboembolic disease with an immune-mediated component, potentially related to the recent surgery and heparin use.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Heparin-Induced Thrombocytopenia (HIT)**

* Recent use of low molecular weight heparin for thromboprophylaxis after knee replacement surgery
* Significant drop in platelet count (from 210 x 10³/μL to 58 x 10³/μL) within 10 days of heparin initiation
* Positive Heparin-PF4 antibody test, which is a specific test for HIT
* Thrombocytopenia occurred within 5-10 days of heparin exposure, which is a typical timeframe for HIT
* Presence of thrombosis (DVT) despite heparin therapy, which is a paradoxical feature of HIT

**2. Deep Vein Thrombosis (DVT)**

* Recent surgery (knee replacement) and hospitalization, which are risk factors for DVT
* Swelling, pain, and erythema in the right leg, which are classic symptoms of DVT
* Positive Homans' sign, which suggests DVT
* Ultrasound confirmation of a thrombus in the right femoral vein, which is diagnostic of DVT
* Elevated D-dimer level, which is a sensitive marker for DVT (although not specific)

**3. Thromboembolic Disease with Immune-Mediated Thrombocytopenia**

* Recent surgery and hospitalization, which can trigger a prothrombotic state
* Presence of thrombocytopenia, which can be seen in immune-mediated thrombocytopenia (e.g., due to autoantibodies)
* Petechiae on both forearms, which suggest a bleeding tendency and possible immune-mediated thrombocytopenia
* Intermittent fever and palpitations, which could be signs of a systemic inflammatory response or cardiac involvement
* Elevated D-dimer level, which suggests ongoing thrombosis or thromboembolism

Note that while these findings support each diagnosis, the combination of thrombocytopenia, positive Heparin-PF4 antibody test, and DVT is highly suggestive of HIT as the primary diagnosis.","Here are the findings that oppose or do not support each of the possible diagnoses:

**1. Heparin-Induced Thrombocytopenia (HIT)**

* The patient's platelet count did not drop to a level typically seen in HIT (usually < 20 x 10³/μL) within 1-2 days of heparin initiation, but rather dropped over a period of 10 days
* No report of skin necrosis or other typical skin lesions associated with HIT
* No mention of a previous history of HIT or heparin exposure, which can increase the risk of developing HIT
* The patient's vital signs, such as blood pressure and pulse, are relatively stable, whereas patients with HIT may exhibit more significant hemodynamic instability

**2. Deep Vein Thrombosis (DVT)**

* The patient does not report any classic symptoms of DVT, such as shortness of breath or chest pain, which could suggest pulmonary embolism (a common complication of DVT)
* No mention of a family history of DVT or thrombophilia, which can increase the risk of developing DVT
* The patient's physical examination does not reveal any signs of phlegmasia cerulea dolens (a severe form of DVT characterized by cyanosis and edema)
* The patient's D-dimer level, while elevated, is not extremely high (e.g., > 10 μg/mL), which might be expected in a more severe case of DVT

**3. Thromboembolic Disease with Immune-Mediated Thrombocytopenia**

* The patient's laboratory results do not show any evidence of anemia, leukocytosis, or elevated inflammatory markers (e.g., CRP, ESR), which might be expected in a systemic inflammatory response
* No report of any autoimmune disorders or conditions that could increase the risk of immune-mediated thrombocytopenia (e.g., lupus, rheumatoid arthritis)
* The patient's physical examination does not reveal any signs of splenomegaly or lymphadenopathy, which can be associated with immune-mediated thrombocytopenia
* The patient's cardiac examination is relatively normal, with no murmurs or gallops, which might be expected if there were significant cardiac involvement (e.g., due to emboli or inflammation)

These opposing findings highlight the complexity of the patient's presentation and the need for careful consideration of multiple diagnoses. However, the presence of a positive Heparin-PF4 antibody test and thrombocytopenia in the context of recent heparin exposure still strongly suggests HIT as the primary diagnosis.","Based on the patient's symptoms, laboratory results, and physical examination, the final diagnosis is:

**Heparin-Induced Thrombocytopenia (HIT)**

The diagnosis of HIT is supported by the following key findings:

1. **Recent heparin exposure**: The patient received prophylactic low molecular weight heparin after knee replacement surgery.
2. **Thrombocytopenia**: The patient's platelet count dropped significantly from 210 x 10³/μL to 58 x 10³/μL within 10 days of heparin initiation.
3. **Positive Heparin-PF4 antibody test**: This is a specific test for HIT, and the positive result confirms the diagnosis.
4. **Thrombosis**: The patient has a DVT, which is a common complication of HIT.
5. **Timing**: The thrombocytopenia and thrombosis occurred within a timeframe consistent with HIT (typically 5-10 days after heparin initiation).

The presence of DVT is also confirmed by the ultrasound findings, but it is likely a complication of the underlying HIT rather than a separate diagnosis.

The patient's symptoms, such as intermittent fever, palpitations, and petechiae, are also consistent with HIT, although they are not specific to this diagnosis.

Overall, the combination of recent heparin exposure, thrombocytopenia, positive Heparin-PF4 antibody test, and thrombosis makes HIT the most likely diagnosis.","Based on the diagnosis of Heparin-Induced Thrombocytopenia (HIT), the following additional steps should be taken:

1. **Discontinue all forms of heparin**: Immediately stop all heparin therapy, including low molecular weight heparin, to prevent further platelet activation and thrombosis.
2. **Initiate alternative anticoagulation**: Start an alternative anticoagulant, such as argatroban, fondaparinux, or danaparoid, to prevent further thrombosis and manage the existing DVT.
3. **Monitor platelet count**: Closely monitor the patient's platelet count to assess the response to treatment and adjust the anticoagulation regimen as needed.
4. **Assess for thrombosis extension or recurrence**: Regularly assess the patient for signs and symptoms of thrombosis extension or recurrence, such as worsening leg swelling, pain, or shortness of breath.
5. **Consider warfarin initiation**: Once the platelet count has recovered (usually > 150 x 10³/μL), consider initiating warfarin therapy to provide long-term anticoagulation and prevent further thrombosis.
6. **Bridge therapy**: Use a bridging anticoagulant, such as argatroban or fondaparinux, until the international normalized ratio (INR) is therapeutic (usually > 2.0) on warfarin.
7. **Patient education**: Educate the patient on the risks and benefits of anticoagulation therapy, the importance of regular follow-up, and the need to report any signs or symptoms of thrombosis or bleeding.
8. **Consultation with a hematologist**: Consider consulting a hematologist for guidance on managing HIT and anticoagulation therapy, particularly if the patient has a complex clinical presentation or requires long-term anticoagulation.
9. **Thrombophilia screening**: Consider screening the patient for underlying thrombophilic conditions, such as factor V Leiden or antithrombin deficiency, to assess the risk of future thrombosis.
10. **Documentation and communication**: Document the diagnosis of HIT and the treatment plan in the patient's medical record, and communicate the diagnosis and treatment plan to all relevant healthcare providers to ensure consistent care.

By taking these additional steps, the patient's risk of further thrombosis and bleeding can be minimized, and the best possible outcome can be achieved.","{""Score"":2,""Rationale"":""The answer includes Heparin-Induced Thrombocytopenia (HIT) and Deep Vein Thrombosis (DVT), which match two of the three required concepts. The third listed diagnosis does not match the required 'Fat embolism', so no point for it.""}","{""Score"":4,""Rationale"":""The answer correctly includes Heparin-Induced Thrombocytopenia and Deep Vein Thrombosis, matching two of the three rubric concepts (2 points each). The third diagnosis provided does not correspond to Fat Embolism from the rubric, so no points are awarded for it. Total score is 4 out of 6.""}","{""Score"":4,""Rationale"":""Student correctly identified opposing findings for HIT and DVT, matching the rubric concepts (2 points each). The third diagnosis provided was not Fat Embolism as required, so no points were awarded for that portion.""}","{""Score"":2,""Rationale"":""Student correctly identified HIT and listed recent heparin use, thrombocytopenia, positive Heparin-PF4 antibody test, thrombosis and petechiae, matching the high‑scoring example.""}","{""Score"":6,""Rationale"":""The answer includes all three required actions: immediate discontinuation of all heparin, initiation of alternative anticoagulation (argatroban/fondaparinux), and close monitoring of platelet count, matching the high‑scoring example.""}",18.0
"History of Present Illness
A 44-year-old female presents with a 6-month history of unintentional weight gain, especially in her abdomen and face. She notes the appearance of purple striae on her abdomen and has recently developed increased acne and facial hair growth. She reports fatigue, insomnia, and mood swings. Over the last month, she has had progressive weakness in her legs, which is most noticeable when climbing stairs.

Past Medical History
The patient has a history of polycystic ovary syndrome (PCOS), for which she has been treated intermittently with oral contraceptives. She denies any history of diabetes or previous steroid use.

Physical Examination
VITALS: BP 170/110 mmHg, pulse 82/min, temperature 98.5°F.
GEN: Overweight, with moon facies and a central distribution of fat.
CARDIAC: Regular rhythm, no murmurs.
PULM: Clear to auscultation bilaterally.
ABD: Obese with prominent abdominal striae and a rounded abdomen.
EXT: Bilateral proximal muscle weakness, especially in the thighs.
SKIN: Purple striae on the abdomen, mild acne on the back and face.

Laboratory Results
Serum cortisol levels are elevated, with a 24-hour urine cortisol excretion of 500 μg/day (normal: <50 μg/day). ACTH is raised, and MRI of the pituitary gland shows a small adenoma.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Cushing's Syndrome**: The patient's symptoms such as weight gain, particularly in the abdominal and facial areas, purple striae, acne, facial hair growth, and muscle weakness are consistent with Cushing's syndrome. The elevated serum cortisol levels and 24-hour urine cortisol excretion also support this diagnosis.
2. **Cushing's Disease**: The presence of a pituitary adenoma on MRI, elevated ACTH, and elevated cortisol levels suggest that the patient may have Cushing's disease, which is a specific type of Cushing's syndrome caused by an ACTH-secreting pituitary tumor.
3. **Adrenal Cushing's Syndrome (less likely)**: Although less likely given the elevated ACTH levels, adrenal Cushing's syndrome is still a possible diagnosis. This condition is caused by excess cortisol production by the adrenal glands, which could be due to an adrenal tumor or hyperplasia. However, the presence of a pituitary adenoma and elevated ACTH levels make this diagnosis less likely.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Cushing's Syndrome**

* Supporting findings:
	+ Weight gain, particularly in the abdominal and facial areas (central obesity)
	+ Purple striae on the abdomen
	+ Acne and facial hair growth (hirsutism)
	+ Muscle weakness, particularly in the proximal muscles (thighs)
	+ Elevated serum cortisol levels and 24-hour urine cortisol excretion
	+ Hypertension (BP 170/110 mmHg)
* Risk factors:
	+ History of polycystic ovary syndrome (PCOS), which may increase the risk of developing Cushing's syndrome

**2. Cushing's Disease**

* Supporting findings:
	+ Elevated ACTH levels, which suggest that the excess cortisol production is driven by an ACTH-secreting tumor
	+ Presence of a pituitary adenoma on MRI, which is consistent with an ACTH-secreting pituitary tumor
	+ Elevated serum cortisol levels and 24-hour urine cortisol excretion
	+ Clinical symptoms consistent with Cushing's syndrome (weight gain, striae, acne, hirsutism, muscle weakness)
* Risk factors:
	+ None specific, but the presence of a pituitary adenoma increases the likelihood of Cushing's disease

**3. Adrenal Cushing's Syndrome (less likely)**

* Supporting findings:
	+ Elevated serum cortisol levels and 24-hour urine cortisol excretion (although this could also be seen in Cushing's disease)
	+ Clinical symptoms consistent with Cushing's syndrome (weight gain, striae, acne, hirsutism, muscle weakness)
* Risk factors:
	+ None specific, but a family history of adrenal tumors or hyperplasia could increase the risk
	+ Note: The elevated ACTH levels and presence of a pituitary adenoma make this diagnosis less likely, as adrenal Cushing's syndrome is typically associated with low or undetectable ACTH levels.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Cushing's Syndrome**

* Opposing findings:
	+ The patient's symptoms have developed relatively slowly over 6 months, whereas Cushing's syndrome can cause more rapid onset of symptoms
	+ The patient does not report any significant changes in appetite or food intake, which is often increased in Cushing's syndrome
	+ The patient's sleep disturbances are reported as insomnia, whereas Cushing's syndrome often causes insomnia due to cortisol-induced alertness, but can also cause fatigue and lethargy
* Expected findings that are not present:
	+ Hyperglycemia (elevated blood sugar) is often seen in Cushing's syndrome, but the patient's laboratory results do not mention this
	+ Osteoporosis or decreased bone density is a common finding in Cushing's syndrome, but the patient's examination does not mention this
	+ The patient's cardiac examination is normal, whereas Cushing's syndrome can cause hypertension, cardiac hypertrophy, and other cardiac abnormalities

**2. Cushing's Disease**

* Opposing findings:
	+ The patient's ACTH levels are elevated, but not extremely high, which could suggest a non-pituitary source of ACTH production
	+ The patient's pituitary adenoma is described as small, which may not be sufficient to cause the significant cortisol excess seen in this patient
* Expected findings that are not present:
	+ Visual field defects or other symptoms of pituitary tumor compression are not reported, which could be expected if the pituitary adenoma was larger or more aggressive
	+ The patient's prolactin levels are not mentioned, which could be elevated in some cases of pituitary adenoma
	+ The patient's thyroid function tests are not mentioned, which could be abnormal in some cases of Cushing's disease due to the effects of cortisol on thyroid hormone metabolism

**3. Adrenal Cushing's Syndrome (less likely)**

* Opposing findings:
	+ The patient's ACTH levels are elevated, which is not typical of adrenal Cushing's syndrome, where ACTH levels are usually low or undetectable
	+ The patient's pituitary gland shows a small adenoma on MRI, which suggests a pituitary source of ACTH production rather than an adrenal source
* Expected findings that are not present:
	+ Low or undetectable ACTH levels, which are typically seen in adrenal Cushing's syndrome
	+ Elevated levels of other adrenal hormones, such as aldosterone or androgens, which could be expected in adrenal Cushing's syndrome
	+ A palpable abdominal mass or other signs of adrenal tumor, which are not reported in this patient","Based on the patient's symptoms, physical examination, laboratory results, and imaging studies, the final diagnosis is:

**Cushing's Disease**

The diagnosis of Cushing's disease is supported by the following findings:

* Elevated serum cortisol levels and 24-hour urine cortisol excretion, which indicate excess cortisol production
* Elevated ACTH levels, which suggest that the excess cortisol production is driven by an ACTH-secreting tumor
* Presence of a small pituitary adenoma on MRI, which is consistent with an ACTH-secreting pituitary tumor
* Clinical symptoms consistent with Cushing's syndrome, including weight gain, purple striae, acne, hirsutism, muscle weakness, and hypertension
* The patient's symptoms and laboratory results are consistent with the diagnosis of Cushing's disease, and the presence of a pituitary adenoma on MRI provides strong evidence for this diagnosis.

The diagnosis of Cushing's disease is further supported by the fact that the patient's ACTH levels are elevated, which is consistent with an ACTH-secreting pituitary tumor. The presence of a small pituitary adenoma on MRI also supports this diagnosis, as it is likely that the adenoma is producing excess ACTH, leading to the patient's symptoms and laboratory abnormalities.

In contrast, adrenal Cushing's syndrome is less likely, as the patient's ACTH levels are elevated, which is not typical of adrenal Cushing's syndrome. Additionally, the presence of a pituitary adenoma on MRI suggests a pituitary source of ACTH production, rather than an adrenal source.

Overall, the combination of clinical symptoms, laboratory results, and imaging studies provides strong evidence for the diagnosis of Cushing's disease.","Based on the final diagnosis of Cushing's disease, the following additional steps can be taken:

1. **Confirmatory testing**: Perform a high-dose dexamethasone suppression test to confirm the diagnosis of Cushing's disease. This test can help differentiate between Cushing's disease and other forms of Cushing's syndrome.
2. **Pituitary gland evaluation**: Perform a thorough evaluation of the pituitary gland, including:
	* MRI of the pituitary gland with gadolinium enhancement to better characterize the adenoma
	* Pituitary function tests to assess the function of the pituitary gland and the production of other hormones
3. **Surgical evaluation**: Refer the patient to a neurosurgeon for evaluation of surgical options to remove the pituitary adenoma. Transsphenoidal surgery is a common approach for removing pituitary adenomas.
4. **Medical management**: Initiate medical therapy to control the symptoms of Cushing's disease, such as:
	* Glucocorticoid receptor antagonists (e.g., mifepristone) to block the effects of excess cortisol
	* Medications to control blood pressure, blood sugar, and other metabolic abnormalities
5. **Monitoring**: Regularly monitor the patient's:
	* Blood pressure and blood sugar levels
	* Electrolyte and fluid balance
	* Bone density and osteoporosis risk
	* Mental health and mood
6. **Endocrinology consultation**: Consult with an endocrinologist to discuss the patient's treatment options and to develop a long-term management plan.
7. **Consideration of other treatments**: Consider other treatment options, such as:
	* Radiation therapy to shrink the pituitary adenoma
	* Medications to reduce cortisol production (e.g., ketoconazole, metyrapone)
	* Bilateral adrenalectomy (removal of both adrenal glands) in severe cases of Cushing's disease that are refractory to other treatments.
8. **Psychological support**: Provide psychological support and counseling to the patient to help them cope with the diagnosis and treatment of Cushing's disease.

By taking these additional steps, the patient can receive comprehensive care and management for their Cushing's disease, and their symptoms and quality of life can be improved.","{""Score"":2,""Rationale"":""The answer includes Cushing's Disease and Cushing's Syndrome, which match two of the three rubric items; Polycystic Ovary Syndrome is missing, so 2 of 3 points earned.""}","{""Score"":4,""Rationale"":""The answer includes the key findings for Cushing's Disease and Cushing's Syndrome that match the rubric, earning 2 points each. It does not present PCOS as a diagnosis nor list its specific rubric points, so no points are awarded for that category.""}","{""Score"":0,""Rationale"":""The response does not contain any of the specific concepts or keywords outlined in the rubric for Cushing's Disease, Cushing’s Syndrome/Exogenous Steroids, or PCOS, so no points are awarded.""}","{""Score"":2,""Rationale"":""Student correctly identified Cushing's Disease and provided the key rubric concepts: weight gain, purple striae, elevated cortisol, and pituitary adenoma, matching the high‑scoring example.""}","{""Score"":4,""Rationale"":""The answer includes a dexamethasone suppression test (matches rubric item 1) and an endocrinology consultation/referral (matches rubric item 3), each worth 2 points. It does not mention ACTH measurement, so no points for item 2.""}",12.0
"History Of Present Illness 
A 76-year-old male presents to his primary care physician with complaints of back and thigh pain lasting for 2 weeks. He reports no pain while sitting or lying down, but walking induces severe pain in his lower back, buttocks, and calves. He also feels fatigued and slightly febrile. A referring cardiologist noted recent test results, since the onset of pain, showing a new anemia and azotemia. Notably, a few days prior to the onset of his symptoms, the patient underwent coronary angioplasty, during which he received heparin for 48 hours.
Past Medical History 
Ischemic heart disease had first been diagnosed ten years earlier, at which time a coronary artery bypass procedure was done. 
Physical Examination 
VITALS: 99.6° F.; pulse was 94/min and regular; BP was 110/88 mmHg. 
GEN: Well appearing 
CARDS: There is a grade III/VI apical systolic murmur. 
PULM: Lungs are clear to auscultation bilaterally, no wheezing, or consolidations noted. 
ABD: Soft, non-tender to palpation 
MSK: He does not have tenderness of his spine or pelvis. Spinal mobility is normal, as is the mobility of his hips. Standing is painless; however, pain is experienced in his low back, buttocks and calves within a minute of feeble running in place. The pain disappears shortly after exercise is discontinued. 
EXT: Peripheral pulses were symmetrically reduced, but palpable. The neurological examination was normal. 
SKIN: Patient has a purple, red, lacy rash over his low back and buttocks. 
Laboratory 
WBC of 11.5 x 103 cells /μL; differential of 64% segs, 20% lymphocytes, 3% monocytes, 12% eosinophils and 1% basophil. The hematocrit was 28% and the platelet count was 315 x 103 /μL. The erythrocyte sedimentation rate was 99 mm/h. Urinalysis was normal except for 2+ proteinuria. Serum creatinine was 4.0 mg/dL; sodium was 145 mEq/L; potassium 4.0 mEq/L; chloride 105 mEq/L. SGOT was 27 U/L; GGT was 90 U/L; alkaline phosphatase was 153 U/L.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Aortic Dissection**: The patient's severe back and thigh pain, which is exacerbated by walking and relieved by rest, could be indicative of an aortic dissection. The recent coronary angioplasty and heparin use may have contributed to the development of an aortic dissection.
2. **Cholesterol Crystal Embolization (CCE)**: The patient's recent coronary angioplasty and heparin use may have dislodged cholesterol crystals, which could have embolized to smaller arteries, causing inflammation and damage. The patient's symptoms, such as back and thigh pain, fatigue, and febrile state, are consistent with CCE.
3. **Vasculitis (e.g., Giant Cell Arteritis or Polyarteritis Nodosa)**: The patient's elevated erythrocyte sedimentation rate (ESR), anemia, and azotemia, combined with the presence of a purple, red, lacy rash over his low back and buttocks, could suggest an underlying vasculitis. The patient's age and symptoms are also consistent with giant cell arteritis or polyarteritis nodosa.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Aortic Dissection**

* Supporting findings:
	+ Severe back and thigh pain, which is exacerbated by walking and relieved by rest
	+ Recent coronary angioplasty and heparin use, which may have increased the risk of aortic dissection
	+ Presence of a grade III/VI apical systolic murmur, which could indicate aortic regurgitation, a common complication of aortic dissection
	+ Elevated blood pressure (110/88 mmHg) may have contributed to the development of an aortic dissection
* Risk factors:
	+ Age (76 years old) - aortic dissections are more common in older adults
	+ History of ischemic heart disease and coronary artery bypass procedure, which may have increased the risk of aortic dissection
	+ Recent use of anticoagulation (heparin) during coronary angioplasty, which may have increased the risk of bleeding and aortic dissection

**2. Cholesterol Crystal Embolization (CCE)**

* Supporting findings:
	+ Recent coronary angioplasty and heparin use, which may have dislodged cholesterol crystals and caused embolization
	+ Presence of a purple, red, lacy rash over the low back and buttocks, which could be a sign of livedo reticularis, a common finding in CCE
	+ Elevated creatinine (4.0 mg/dL) and proteinuria, which could indicate renal involvement due to CCE
	+ Anemia and azotemia, which could be caused by CCE-induced renal damage
* Risk factors:
	+ Age (76 years old) - CCE is more common in older adults
	+ History of ischemic heart disease and coronary artery bypass procedure, which may have increased the risk of CCE
	+ Recent use of anticoagulation (heparin) during coronary angioplasty, which may have increased the risk of CCE

**3. Vasculitis (e.g., Giant Cell Arteritis or Polyarteritis Nodosa)**

* Supporting findings:
	+ Elevated erythrocyte sedimentation rate (ESR) (99 mm/h), which is a common finding in vasculitis
	+ Presence of a purple, red, lacy rash over the low back and buttocks, which could be a sign of vasculitis
	+ Anemia and azotemia, which could be caused by vasculitis-induced renal damage
	+ Fatigue and febrile state, which are common symptoms of vasculitis
* Risk factors:
	+ Age (76 years old) - giant cell arteritis is more common in older adults
	+ Presence of a grade III/VI apical systolic murmur, which could indicate aortic regurgitation, a common complication of giant cell arteritis
	+ Elevated WBC count (11.5 x 10^3 cells/μL) and differential, which could indicate an inflammatory process such as vasculitis","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Aortic Dissection**

* Opposing findings:
	+ The patient's blood pressure is not excessively high (110/88 mmHg), which is often seen in aortic dissection
	+ The patient's pain is not typically tearing or ripping in nature, which is a classic description of aortic dissection pain
	+ The patient's physical examination does not reveal any signs of aortic regurgitation, such as a diastolic murmur, which is often present in aortic dissection
	+ The patient's peripheral pulses are symmetrically reduced, but palpable, which does not suggest a significant discrepancy in pulse strength between the upper and lower extremities, as might be expected in aortic dissection
* Expected findings not present:
	+ Mediastinal widening on chest X-ray, which is often seen in aortic dissection
	+ Pericardial effusion on echocardiogram, which can occur in aortic dissection
	+ Electrocardiogram changes, such as ST-segment elevation or depression, which can occur in aortic dissection

**2. Cholesterol Crystal Embolization (CCE)**

* Opposing findings:
	+ The patient's renal function is significantly impaired (creatinine 4.0 mg/dL), which is not typically seen in CCE
	+ The patient's skin rash is not typically described as livedo reticularis, which is a common finding in CCE
	+ The patient's laboratory results do not show significant eosinophilia, which is often seen in CCE
* Expected findings not present:
	+ Embolic phenomena, such as digital ischemia or gangrene, which can occur in CCE
	+ Retinal emboli on fundoscopic examination, which can occur in CCE
	+ Significant elevation in liver function tests, which can occur in CCE

**3. Vasculitis (e.g., Giant Cell Arteritis or Polyarteritis Nodosa)**

* Opposing findings:
	+ The patient's age is not typical for giant cell arteritis, which usually presents in patients over 80 years old
	+ The patient's symptoms are not typical for giant cell arteritis, which usually presents with headache, jaw claudication, and visual disturbances
	+ The patient's laboratory results do not show significant elevation in alkaline phosphatase, which is often seen in giant cell arteritis
* Expected findings not present:
	+ Jaw claudication or visual disturbances, which are common symptoms of giant cell arteritis
	+ Temporal artery tenderness or swelling, which is often present in giant cell arteritis
	+ Significant elevation in C-reactive protein or interleukin-6, which can occur in vasculitis

Note that these opposing findings do not necessarily rule out each diagnosis, but rather suggest that the diagnosis may be less likely or that additional evaluation is needed to confirm the diagnosis.","Based on the patient's symptoms, laboratory results, and physical examination, the final diagnosis is:

**Cholesterol Crystal Embolization (CCE)**

The diagnosis of CCE is supported by the following findings:

* Recent coronary angioplasty and heparin use, which may have dislodged cholesterol crystals and caused embolization
* Presence of a purple, red, lacy rash over the low back and buttocks, which could be a sign of livedo reticularis, a common finding in CCE
* Elevated creatinine (4.0 mg/dL) and proteinuria, which could indicate renal involvement due to CCE
* Anemia and azotemia, which could be caused by CCE-induced renal damage
* Elevated erythrocyte sedimentation rate (ESR) (99 mm/h), which is a non-specific marker of inflammation that can be elevated in CCE
* The patient's symptoms, such as back and thigh pain, fatigue, and febrile state, are consistent with CCE

While the patient's symptoms and laboratory results could also be consistent with other diagnoses, such as vasculitis or aortic dissection, the presence of recent coronary angioplasty and heparin use, combined with the characteristic rash and renal involvement, make CCE the most likely diagnosis.

It's worth noting that CCE is a diagnosis that is often made clinically, and imaging studies such as CT or MRI may not always show specific findings. However, the patient's clinical presentation and laboratory results are consistent with CCE, and further evaluation and treatment should be guided by this diagnosis.","Based on the final diagnosis of Cholesterol Crystal Embolization (CCE), the following additional steps should be taken:

1. **Stop anticoagulation**: Immediately discontinue any anticoagulation therapy, including heparin, to prevent further embolization of cholesterol crystals.
2. **Supportive care**: Provide supportive care to manage the patient's symptoms, including pain management, hydration, and monitoring of renal function.
3. **Renal replacement therapy**: Consider initiating renal replacement therapy, such as hemodialysis, if the patient's renal function continues to deteriorate.
4. **Imaging studies**: Consider ordering imaging studies, such as:
	* CT angiogram or MRI to evaluate the extent of embolization and to rule out other diagnoses, such as aortic dissection.
	* Ultrasound or CT scan to evaluate the patient's kidneys and to assess for any signs of infarction or damage.
5. **Consultation with a nephrologist**: Consult with a nephrologist to manage the patient's renal failure and to provide guidance on renal replacement therapy.
6. **Consultation with a cardiologist**: Consult with a cardiologist to manage the patient's cardiovascular disease and to provide guidance on the management of the patient's coronary artery disease.
7. **Monitoring**: Closely monitor the patient's:
	* Renal function, including creatinine and urine output.
	* Electrolyte levels, including potassium and phosphate.
	* Blood pressure and cardiac function.
	* Pain and symptoms, and adjust the treatment plan as needed.
8. **Consideration of steroid therapy**: Consider starting steroid therapy, such as prednisone, to reduce inflammation and to prevent further embolization of cholesterol crystals.
9. **Follow-up**: Schedule follow-up appointments with the patient to monitor their condition and to adjust the treatment plan as needed.

By taking these additional steps, the patient's condition can be managed, and the risk of further complications can be reduced.","{""Score"":1,""Rationale"":""Only 'Cholesterol Crystal Embolization' matches the rubric's 'Cholesterol embolism'; the other two diagnoses are not listed in the rubric.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Cholesterol Crystal Embolization, which matches the rubric's Cholesterol embolism (2 points). It does not include Acute interstitial nephritis or Peripheral arterial disease, so no points for those.""}","{""Score"":2,""Rationale"":""The answer only addresses cholesterol embolism (listed as cholesterol crystal embolization), matching one of the three required concepts (2 points). It does not mention acute interstitial nephritis or peripheral arterial disease, so no points for those.""}","{""Score"":2,""Rationale"":""Student correctly identified cholesterol embolism (Cholesterol Crystal Embolization), matching the high‑scoring answer.""}","{""Score"":0,""Rationale"":""The answer does not include arterial ultrasounds of the lower extremities or ABI, does not mention analyzing urine for casts/eosinophils (only a nephrology consult), and does not consider a renal biopsy. Therefore, none of the rubric items are met.""}",7.0
"History of Present Illness
A 42-year-old male presents with chronic burning pain in his hands and feet, which has worsened over the past year. He has frequent episodes of abdominal cramping and diarrhea. He reports fatigue, decreased exercise tolerance, and intermittent difficulty with vision. He recalls a history of a similar condition in his older brother, who died from kidney failure at the age of 48. 

Past Medical History
The patient has been diagnosed with chronic kidney disease of unknown etiology. He also has a history of hearing loss and occasional headaches. There is a history of diabetes and hypertension. 

Physical Examination
VITALS: BP 150/90 mmHg, pulse 82/min, temperature 98.6°F. 
GEN: Thin, mildly fatigued. 
HEENT: Corneal opacities visible on slit lamp examination. 
CARDIAC: No murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Non-tender, hepatosplenomegaly noted. 
EXT: Angiokeratomas on the lower abdomen and upper thighs. 
SKIN: No significant rashes. 

Laboratory Results
Serum creatinine is elevated at 2.8 mg/dL. Urinalysis shows 3+ proteinuria with no red blood cells. Alpha-galactosidase A activity in plasma is significantly reduced.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Fabry Disease**: This is a genetic disorder caused by a deficiency of alpha-galactosidase A, which is consistent with the significantly reduced enzyme activity in the patient's plasma. The disease can cause a range of symptoms, including chronic burning pain in the hands and feet, abdominal cramping, diarrhea, fatigue, and kidney disease.
2. **Diabetic Neuropathy**: The patient's history of diabetes and symptoms such as chronic burning pain in the hands and feet, fatigue, and decreased exercise tolerance could be consistent with diabetic neuropathy. However, the presence of other symptoms such as corneal opacities, angiokeratomas, and significantly reduced alpha-galactosidase A activity suggest that Fabry disease may be a more likely diagnosis.
3. **Amyloidosis**: This is a group of diseases characterized by the deposition of abnormal proteins (amyloid) in various tissues, which can cause a range of symptoms including kidney disease, neuropathy, and gastrointestinal symptoms. However, the presence of significantly reduced alpha-galactosidase A activity and angiokeratomas on the skin suggest that Fabry disease is a more likely diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Fabry Disease**

* **Significantly reduced alpha-galactosidase A activity in plasma**: This is a key diagnostic finding for Fabry disease, as the disease is caused by a deficiency of this enzyme.
* **Family history of similar condition**: The patient's older brother died from kidney failure at a young age, which could be consistent with Fabry disease, an inherited disorder.
* **Chronic burning pain in hands and feet**: This is a common symptom of Fabry disease, which can cause peripheral neuropathy.
* **Corneal opacities**: These are a common finding in Fabry disease, and can be detected on slit lamp examination.
* **Angiokeratomas on the skin**: These are small, dark red spots on the skin that are characteristic of Fabry disease.
* **Kidney disease**: The patient's chronic kidney disease of unknown etiology could be related to Fabry disease, which can cause progressive kidney damage.
* **Hearing loss**: This is a common symptom of Fabry disease, which can cause auditory neuropathy.

**2. Diabetic Neuropathy**

* **History of diabetes**: The patient has a history of diabetes, which is a major risk factor for diabetic neuropathy.
* **Chronic burning pain in hands and feet**: This is a common symptom of diabetic neuropathy, which can cause peripheral neuropathy.
* **Fatigue and decreased exercise tolerance**: These are common symptoms of diabetes and diabetic neuropathy.
* **Kidney disease**: The patient's chronic kidney disease could be related to diabetes, which can cause diabetic nephropathy.
* **Hypertension**: The patient's high blood pressure could be contributing to kidney disease and neuropathy.

**3. Amyloidosis**

* **Kidney disease**: The patient's chronic kidney disease could be related to amyloidosis, which can cause kidney damage and failure.
* **Neuropathy**: The patient's chronic burning pain in hands and feet could be related to amyloidosis, which can cause peripheral neuropathy.
* **Gastrointestinal symptoms**: The patient's abdominal cramping and diarrhea could be related to amyloidosis, which can cause gastrointestinal involvement.
* **Family history of similar condition**: While the patient's family history is more suggestive of Fabry disease, some forms of amyloidosis can be inherited.
* **Hepatosplenomegaly**: The patient's hepatosplenomegaly could be related to amyloidosis, which can cause organ enlargement.

It's worth noting that while there are some findings that support diabetic neuropathy and amyloidosis, the presence of significantly reduced alpha-galactosidase A activity and angiokeratomas on the skin make Fabry disease a more likely diagnosis.","Here are the findings that oppose each of the possible diagnoses, or findings that were expected but not present:

**1. Fabry Disease**

* **Absence of characteristic cardiac involvement**: Fabry disease often causes cardiac hypertrophy, arrhythmias, and valvular disease, but the patient's cardiac examination is normal.
* **No mention of heat or cold intolerance**: Patients with Fabry disease often experience heat or cold intolerance due to autonomic dysfunction, but this is not mentioned in the patient's history.
* **No gastrointestinal bleeding**: Some patients with Fabry disease experience gastrointestinal bleeding due to angiokeratomas in the gut, but this is not mentioned in the patient's history.
* **Proteinuria without hematuria**: While proteinuria is common in Fabry disease, hematuria is also often present due to kidney involvement. The absence of hematuria is somewhat unexpected.

**2. Diabetic Neuropathy**

* **Absence of typical diabetic neuropathy patterns**: Diabetic neuropathy often presents with a distal, symmetrical pattern of nerve damage, but the patient's symptoms are not clearly described as such.
* **No mention of sensory loss or numbness**: Diabetic neuropathy often causes sensory loss or numbness in the affected areas, but this is not mentioned in the patient's history.
* **Presence of corneal opacities**: Corneal opacities are not a typical finding in diabetic neuropathy, and suggest a different underlying condition.
* **Angiokeratomas not typical of diabetic neuropathy**: The presence of angiokeratomas on the skin is not a typical finding in diabetic neuropathy, and suggests a different underlying condition such as Fabry disease.

**3. Amyloidosis**

* **Absence of macroglossia**: Amyloidosis often causes macroglossia (enlargement of the tongue), but this is not mentioned in the patient's history.
* **No mention of weight loss or malnutrition**: Amyloidosis often causes weight loss and malnutrition due to gastrointestinal involvement, but this is not mentioned in the patient's history.
* **Normal cardiac examination**: Amyloidosis often causes cardiac involvement, including arrhythmias and heart failure, but the patient's cardiac examination is normal.
* **Specific enzyme deficiency**: The presence of a specific enzyme deficiency (alpha-galactosidase A) is not typical of amyloidosis, and suggests a different underlying condition such as Fabry disease.

These findings highlight the importance of considering multiple diagnoses and evaluating the presence or absence of specific symptoms and signs to support or oppose each hypothesis.","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Fabry Disease**

The diagnosis is supported by the following key findings:

1. **Significantly reduced alpha-galactosidase A activity in plasma**: This is a specific and sensitive test for Fabry disease.
2. **Family history of similar condition**: The patient's older brother died from kidney failure at a young age, which is consistent with the natural history of Fabry disease.
3. **Chronic burning pain in hands and feet**: This is a common symptom of Fabry disease, which can cause peripheral neuropathy.
4. **Corneal opacities**: These are a common finding in Fabry disease, and can be detected on slit lamp examination.
5. **Angiokeratomas on the skin**: These are small, dark red spots on the skin that are characteristic of Fabry disease.
6. **Kidney disease**: The patient's chronic kidney disease of unknown etiology is consistent with Fabry disease, which can cause progressive kidney damage.
7. **Hearing loss**: This is a common symptom of Fabry disease, which can cause auditory neuropathy.

The diagnosis of Fabry disease is further supported by the absence of other explanations for the patient's symptoms and signs, and the presence of a specific enzyme deficiency that is characteristic of the disease.

**Treatment and Management:**

The patient should be referred to a specialist in genetic medicine or a Fabry disease treatment center for further evaluation and management. Treatment options may include:

1. **Enzyme replacement therapy (ERT)**: This involves intravenous infusion of alpha-galactosidase A to replace the deficient enzyme.
2. **Pain management**: The patient may require pain management with medications such as gabapentin or pregabalin to control neuropathic pain.
3. **Kidney disease management**: The patient's kidney disease should be managed with standard therapies, including blood pressure control and proteinuria reduction.
4. **Cardiovascular risk reduction**: The patient should be screened for cardiovascular risk factors and managed with standard therapies to reduce the risk of cardiovascular disease.

**Prognosis:**

The prognosis for patients with Fabry disease is variable, but early diagnosis and treatment can significantly improve outcomes. With ERT and other supportive therapies, patients with Fabry disease can experience significant improvement in symptoms and quality of life. However, the disease can still progress over time, and patients require ongoing monitoring and management to prevent complications.","Based on the diagnosis of Fabry disease, the following additional steps should be taken:

1. **Genetic testing**: Confirm the diagnosis with genetic testing to identify the specific mutation in the GLA gene that is causing the disease.
2. **Family screening**: Screen the patient's family members for Fabry disease, as it is an inherited disorder. This includes testing for the specific mutation in the GLA gene.
3. **Cardiac evaluation**: Perform a thorough cardiac evaluation, including echocardiography, electrocardiography, and cardiac MRI, to assess for cardiac involvement.
4. **Renal evaluation**: Perform a thorough renal evaluation, including measurement of glomerular filtration rate (GFR), proteinuria, and hematuria, to assess for renal involvement.
5. **Neurological evaluation**: Perform a thorough neurological evaluation, including electromyography (EMG) and nerve conduction studies (NCS), to assess for neurological involvement.
6. **Ophthalmological evaluation**: Perform a thorough ophthalmological evaluation, including slit lamp examination and visual acuity testing, to assess for ocular involvement.
7. **Auditory evaluation**: Perform a thorough auditory evaluation, including audiometry and tympanometry, to assess for auditory involvement.
8. **Pain management**: Develop a pain management plan to control the patient's neuropathic pain, which may include medications such as gabapentin or pregabalin.
9. **Enzyme replacement therapy (ERT)**: Initiate ERT with agalsidase beta or agalsidase alfa to replace the deficient alpha-galactosidase A enzyme.
10. **Regular follow-up**: Schedule regular follow-up appointments with a specialist in genetic medicine or a Fabry disease treatment center to monitor the patient's disease progression and adjust treatment as needed.

**Additional considerations:**

1. **Pregnancy planning**: Women with Fabry disease should be counseled on the risks of pregnancy and the importance of prenatal testing.
2. **Family planning**: Men and women with Fabry disease should be counseled on the risks of transmitting the disease to their offspring and the importance of genetic testing.
3. **Psychological support**: Provide psychological support to the patient and their family, as Fabry disease can have a significant impact on quality of life.
4. **Social support**: Provide social support to the patient and their family, including connecting them with Fabry disease support groups and resources.

**Long-term management:**

1. **Regular monitoring**: Regularly monitor the patient's disease progression, including cardiac, renal, and neurological evaluations.
2. **Adjusting treatment**: Adjust treatment as needed to control symptoms and slow disease progression.
3. **New therapies**: Consider new therapies as they become available, such as chaperone therapy or gene therapy.
4. **Clinical trials**: Consider enrolling the patient in clinical trials to evaluate new treatments for Fabry disease.","{""Score"":1.5,""Rationale"":""Student correctly identified Fabry Disease (1 mark) and Diabetic Neuropathy (0.5 mark). They did not include Chronic Kidney Disease secondary to Alport Syndrome, Diabetic Nephropathy, or Polyarteritis Nodosa. Total 1.5 out of 3.""}","{""Score"":4,""Rationale"":""The answer includes Fabry Disease and diabetic-related complications, matching two concepts from the high‑scoring example (2 points each). It does not mention CKD secondary to Alport Syndrome or Polyarteritis Nodosa, so those points are not awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies that angiokeratomas and corneal findings rule out diabetic complications, matching the rubric. It does not provide the required 'no opposing findings' for Fabry Disease, nor address CKD/Alport or Polyarteritis Nodosa as specified, so only 2 of the 6 possible points are earned.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Fabry Disease and lists the key clinical features (burning pain, angiokeratomas, corneal opacities, family history, reduced alpha‑galactosidase A activity) matching the high‑scoring example.""}","{""Score"":6,""Rationale"":""Student includes genetic testing, enzyme replacement therapy, and renal evaluation/monitoring, matching all three rubric items.""}",15.5
"History of Present Illness
A 55-year-old female presents with a 3-month history of progressive difficulty swallowing, drooping of her eyelids, and muscle weakness. She reports that her symptoms are worse by the end of the day and improve with rest. She has also noticed difficulty speaking and has frequent choking episodes when drinking liquids. There is no associated pain, and she denies any other systemic symptoms.

  Past Medical History
She has no significant medical history but was diagnosed with hypothyroidism 5 years ago and has been on levothyroxine since then. Family history is unremarkable.

  Physical Examination
VITALS: BP 130/80 mmHg, pulse 75/min, temperature 98.7°F. 
GEN: Well-appearing, no distress. 
HEENT: Ptosis noted in both eyelids, worse on the right side. 
PULM: Clear to auscultation bilaterally. 
NEURO: Proximal muscle weakness
EXT: No edema

  Laboratory Results
Acetylcholine receptor antibodies are positive. Serum creatine kinase (CK) is normal.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Myasthenia Gravis**: The patient's symptoms of progressive difficulty swallowing, drooping of eyelids (ptosis), muscle weakness, and worsening of symptoms by the end of the day are consistent with Myasthenia Gravis. The presence of acetylcholine receptor antibodies also supports this diagnosis.
2. **Amyotrophic Lateral Sclerosis (ALS)**: Although less likely, ALS could be considered due to the patient's symptoms of progressive muscle weakness, difficulty swallowing, and speech difficulties. However, the presence of acetylcholine receptor antibodies and the lack of other typical ALS symptoms (e.g., fasciculations, upper motor neuron signs) make this diagnosis less likely.
3. **Lambert-Eaton Myasthenic Syndrome (LEMS)**: This rare autoimmune disorder can present with similar symptoms to Myasthenia Gravis, including muscle weakness, ptosis, and difficulty swallowing. However, LEMS often has a more gradual onset and may be associated with other systemic symptoms, which are not present in this case. Additionally, LEMS typically has a different antibody profile, but it's still a possible consideration.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Myasthenia Gravis (MG)**

* **Supporting findings:**
	+ Positive acetylcholine receptor antibodies: This is a hallmark of MG and strongly supports the diagnosis.
	+ Ptosis (drooping of eyelids) and proximal muscle weakness: These are classic symptoms of MG.
	+ Worsening of symptoms by the end of the day and improvement with rest: This is a characteristic pattern of MG.
	+ Difficulty swallowing (dysphagia) and speech difficulties: These are common symptoms of MG.
* **Risk factors:**
	+ Female sex: MG is more common in women, especially in the 20-40 age range, but can occur at any age.
	+ Hypothyroidism: There is an association between MG and other autoimmune disorders, including hypothyroidism, which the patient has.

**2. Amyotrophic Lateral Sclerosis (ALS)**

* **Supporting findings:**
	+ Progressive muscle weakness: This is a hallmark of ALS.
	+ Difficulty swallowing (dysphagia) and speech difficulties: These are common symptoms of ALS.
	+ Proximal muscle weakness: This can be seen in ALS, although it's more typical to see a mix of upper and lower motor neuron signs.
* **Risk factors:**
	+ Age: The patient is 55 years old, which is within the typical age range for ALS.
	+ None of the typical risk factors for ALS (e.g., family history, genetic mutations) are mentioned in the case.
* **However, note that:**
	+ The presence of acetylcholine receptor antibodies is not typical of ALS.
	+ The lack of other typical ALS symptoms (e.g., fasciculations, upper motor neuron signs) makes this diagnosis less likely.

**3. Lambert-Eaton Myasthenic Syndrome (LEMS)**

* **Supporting findings:**
	+ Proximal muscle weakness: This is a common symptom of LEMS.
	+ Difficulty swallowing (dysphagia) and speech difficulties: These can be seen in LEMS.
	+ Ptosis (drooping of eyelids): This can occur in LEMS, although it's less common than in MG.
* **Risk factors:**
	+ Age: The patient is 55 years old, which is within the typical age range for LEMS.
	+ None of the typical risk factors for LEMS (e.g., smoking, history of cancer) are mentioned in the case.
* **However, note that:**
	+ The presence of acetylcholine receptor antibodies is more typical of MG than LEMS.
	+ LEMS often has a more gradual onset and may be associated with other systemic symptoms, which are not present in this case.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Myasthenia Gravis (MG)**

* **Opposing findings:**
	+ Normal serum creatine kinase (CK) levels: Elevated CK levels can be seen in MG, especially during exacerbations.
	+ No mention of respiratory muscle weakness: MG can affect respiratory muscles, leading to respiratory failure, but this is not mentioned in the case.
	+ No mention of other autoimmune disorders: MG is often associated with other autoimmune disorders, such as thyroid disease (which the patient has), but also others like rheumatoid arthritis or lupus, which are not mentioned.
* **Expected findings that are not present:**
	+ Ocular symptoms other than ptosis: MG often presents with other ocular symptoms like diplopia (double vision) or nystagmus (abnormal eye movements), which are not mentioned.
	+ Fluctuating symptoms: While the patient's symptoms worsen by the end of the day, MG symptoms can also fluctuate throughout the day, which is not explicitly mentioned.

**2. Amyotrophic Lateral Sclerosis (ALS)**

* **Opposing findings:**
	+ Positive acetylcholine receptor antibodies: This is not typical of ALS, which is more often associated with upper and lower motor neuron signs.
	+ No mention of upper motor neuron signs: ALS typically presents with a mix of upper and lower motor neuron signs, such as hyperreflexia, spasticity, or fasciculations, which are not mentioned.
	+ No mention of muscle atrophy or fasciculations: ALS often leads to muscle atrophy and fasciculations, which are not mentioned in the case.
* **Expected findings that are not present:**
	+ Upper motor neuron signs: As mentioned earlier, ALS typically presents with upper motor neuron signs, which are not present in this case.
	+ Bulbar symptoms: ALS can affect the bulbar region, leading to symptoms like dysarthria (speech difficulties), dysphagia (swallowing difficulties), and drooling, but these are not as prominent as expected.
	+ Progressive weakness in a specific pattern: ALS often presents with a specific pattern of weakness, such as limb-onset or bulbar-onset, which is not clearly described in the case.

**3. Lambert-Eaton Myasthenic Syndrome (LEMS)**

* **Opposing findings:**
	+ Positive acetylcholine receptor antibodies: This is more typical of MG than LEMS, which is often associated with voltage-gated calcium channel (VGCC) antibodies.
	+ No mention of autonomic symptoms: LEMS can present with autonomic symptoms like dry mouth, impotence, or orthostatic hypotension, which are not mentioned.
	+ No mention of cancer: LEMS is often associated with small cell lung cancer or other malignancies, which is not mentioned in the case.
* **Expected findings that are not present:**
	+ VGCC antibodies: LEMS is often associated with VGCC antibodies, which are not mentioned in the case.
	+ Improvement of symptoms with repeated use or exercise: LEMS symptoms often improve with repeated use or exercise, which is not mentioned in the case.
	+ More gradual onset of symptoms: LEMS often has a more gradual onset of symptoms, which is not clearly described in the case.","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Myasthenia Gravis (MG)**

The diagnosis of MG is supported by the following key findings:

1. **Positive acetylcholine receptor antibodies**: This is a hallmark of MG and strongly supports the diagnosis.
2. **Ptosis (drooping of eyelids) and proximal muscle weakness**: These are classic symptoms of MG.
3. **Worsening of symptoms by the end of the day and improvement with rest**: This is a characteristic pattern of MG.
4. **Difficulty swallowing (dysphagia) and speech difficulties**: These are common symptoms of MG.
5. **Normal serum creatine kinase (CK) levels**: While elevated CK levels can be seen in MG, normal levels do not rule out the diagnosis.

The patient's symptoms and laboratory results are most consistent with MG, and the presence of acetylcholine receptor antibodies is a strong indicator of this diagnosis. While ALS and LEMS are possible considerations, the patient's symptoms and laboratory results are less consistent with these diagnoses.

**Treatment and management:**

The patient will likely require treatment with acetylcholinesterase inhibitors, such as pyridostigmine, to improve muscle strength and reduce symptoms. Additionally, the patient may require immunosuppressive therapy, such as prednisone, to reduce the production of acetylcholine receptor antibodies. The patient's hypothyroidism should also be managed with levothyroxine, and the patient should be monitored for any signs of thyroid dysfunction.

**Further evaluation:**

The patient may require further evaluation, including:

1. **Electromyography (EMG) and nerve conduction studies (NCS)**: To assess muscle and nerve function.
2. **Computed tomography (CT) or magnetic resonance imaging (MRI) of the chest**: To rule out thymoma, a type of tumor that can be associated with MG.
3. **Regular follow-up appointments**: To monitor the patient's symptoms and adjust treatment as needed.","Based on the diagnosis of Myasthenia Gravis (MG), the following additional steps can be taken:

**Immediate Steps:**

1. **Initiate treatment with acetylcholinesterase inhibitors**: Start the patient on pyridostigmine, 30-60 mg every 3-4 hours, to improve muscle strength and reduce symptoms.
2. **Monitor for side effects**: Watch for side effects such as nausea, vomiting, diarrhea, and abdominal cramps, which are common with acetylcholinesterase inhibitors.
3. **Adjust medication as needed**: Adjust the dose and frequency of pyridostigmine based on the patient's response and side effects.

**Short-Term Steps:**

1. **Order electromyography (EMG) and nerve conduction studies (NCS)**: Schedule EMG and NCS to assess muscle and nerve function and confirm the diagnosis of MG.
2. **Order computed tomography (CT) or magnetic resonance imaging (MRI) of the chest**: Schedule a CT or MRI of the chest to rule out thymoma, a type of tumor that can be associated with MG.
3. **Refer to a neurologist**: Refer the patient to a neurologist for further evaluation and management of MG.
4. **Educate the patient and family**: Educate the patient and family about MG, its symptoms, treatment options, and prognosis.

**Long-Term Steps:**

1. **Regular follow-up appointments**: Schedule regular follow-up appointments with the patient to monitor their symptoms, adjust treatment as needed, and assess for any signs of disease progression.
2. **Monitor for thymoma**: Continue to monitor the patient for signs of thymoma, such as chest pain, cough, or shortness of breath.
3. **Consider immunosuppressive therapy**: Consider adding immunosuppressive therapy, such as prednisone, to reduce the production of acetylcholine receptor antibodies and improve symptoms.
4. **Consider thymectomy**: Consider referring the patient for a thymectomy, which can be beneficial for patients with MG, especially those with thymoma.

**Additional Tests:**

1. **Repeat acetylcholine receptor antibody test**: Repeat the acetylcholine receptor antibody test to confirm the diagnosis and monitor the patient's response to treatment.
2. **Electrophysiological tests**: Consider ordering electrophysiological tests, such as single-fiber EMG, to assess muscle function and monitor disease progression.
3. **Pulmonary function tests**: Consider ordering pulmonary function tests to assess the patient's respiratory function and monitor for any signs of respiratory muscle weakness.","{""Score"":2,""Rationale"":""The answer includes Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome, which match two of the three required concepts. It does not include Hypothyroid Myopathy, so only 2 of 3 points are awarded.""}","{""Score"":4,""Rationale"":""Student correctly identified Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome with appropriate supporting findings, matching the rubric (2 points each). Hypothyroid Myopathy was not mentioned, so no points for that category.""}","{""Score"":0,""Rationale"":""The answer does not provide the specific opposing findings listed in the rubric for Myasthenia Gravis, Lambert-Eaton Myasthenic Syndrome, or Hypothyroid Myopathy; it includes unrelated or incorrect points and omits Hypothyroid Myopathy entirely.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Myasthenia Gravis and includes the key features from the high‑scoring example (ptosis, bulbar weakness, fatigue improving with rest, positive acetylcholine receptor antibodies), thus meeting the rubric criteria for full credit.""}","{""Score"":2,""Rationale"":""The answer includes ordering a CT or MRI of the chest, matching one rubric item (2 points). It does not mention the Edrophonium (Tensilon) test or assessment of thyroid function, so no points for those.""}",10.0
"History of Present Illness
A 41-year-old male presents with a 4-week history of chronic sinus congestion, bloody nasal discharge, and persistent cough with hemoptysis. He also complains of joint pain and swelling in both knees and ankles. He reports unintentional weight loss of 8 kg over the last 2 months. He denies any recent trauma, travel, or exposure to sick contacts.

  Past Medical History
The patient has no significant medical history but was previously healthy. He has no known drug allergies and does not smoke or drink alcohol.

  Physical Examination
VITALS: BP 120/78 mmHg, pulse 88/min, temperature 99.2°F. 
GEN: Well-appearing but fatigued. 
HEENT: Nasal mucosal ulcerations, bloody discharge from both nostrils. 
PULM: Bilateral rales in the lungs. 
ABD: Soft, non-tender. 
EXT: Swelling in both knees and ankles, with mild erythema. 
SKIN: No rashes.

  Laboratory Results
WBC count is 12.8 x 103/μL, with a mild left shift. ESR is elevated at 75 mm/h. Serum creatinine is 1.5 mg/dL, and urinalysis shows 1+ proteinuria with RBC casts. c-ANCA is positive. Chest CT shows multiple nodular lung infiltrates and cavities.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**: This is a type of vasculitis that affects small- and medium-sized blood vessels, and is characterized by the presence of c-ANCA. The patient's symptoms, such as sinus congestion, bloody nasal discharge, hemoptysis, and kidney involvement (elevated serum creatinine and proteinuria with RBC casts), are consistent with GPA.
2. **Microscopic Polyangiitis (MPA)**: This is another type of vasculitis that affects small blood vessels, and can present with similar symptoms to GPA, including kidney involvement and lung nodules. However, MPA is typically associated with p-ANCA rather than c-ANCA.
3. **Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)**: This is a type of vasculitis that is characterized by the presence of asthma, eosinophilia, and vasculitis affecting multiple organs. While the patient does not have a history of asthma, the presence of sinus congestion, bloody nasal discharge, and lung nodules could be consistent with this diagnosis. However, the lack of eosinophilia in the laboratory results makes this diagnosis less likely.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

* **c-ANCA positivity**: The patient's positive c-ANCA result is a strong indicator of GPA, as this antibody is found in approximately 80-90% of patients with active GPA.
* **Upper and lower respiratory tract involvement**: The patient's symptoms of chronic sinus congestion, bloody nasal discharge, and hemoptysis are consistent with the upper and lower respiratory tract involvement seen in GPA.
* **Renal involvement**: The patient's elevated serum creatinine, proteinuria with RBC casts, and mild left shift on WBC count are all consistent with renal involvement, which is a common feature of GPA.
* **Systemic symptoms**: The patient's unintentional weight loss, fatigue, and joint pain are all consistent with the systemic nature of GPA.

**2. Microscopic Polyangiitis (MPA)**

* **Renal involvement**: The patient's elevated serum creatinine, proteinuria with RBC casts, and mild left shift on WBC count are all consistent with renal involvement, which is a common feature of MPA.
* **Pulmonary involvement**: The patient's symptoms of hemoptysis and bilateral rales on lung exam, as well as the multiple nodular lung infiltrates and cavities on chest CT, are consistent with the pulmonary involvement seen in MPA.
* **Systemic symptoms**: The patient's unintentional weight loss, fatigue, and joint pain are all consistent with the systemic nature of MPA.
* **Note**: However, the patient's c-ANCA positivity is not typical of MPA, which is usually associated with p-ANCA. This makes MPA a less likely diagnosis.

**3. Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)**

* **Asthma-like symptoms**: The patient's chronic sinus congestion could be consistent with the asthma-like symptoms seen in Churg-Strauss Syndrome.
* **Pulmonary involvement**: The patient's symptoms of hemoptysis and bilateral rales on lung exam, as well as the multiple nodular lung infiltrates and cavities on chest CT, are consistent with the pulmonary involvement seen in Churg-Strauss Syndrome.
* **Systemic symptoms**: The patient's unintentional weight loss, fatigue, and joint pain are all consistent with the systemic nature of Churg-Strauss Syndrome.
* **Note**: However, the patient lacks a history of asthma, and there is no mention of eosinophilia in the laboratory results, which is a key feature of Churg-Strauss Syndrome. This makes Churg-Strauss Syndrome a less likely diagnosis.","Here are the findings that oppose each of the possible diagnoses, or findings that were expected but not present:

**1. Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

* **Lack of granulomatous inflammation on physical exam**: While the patient has nasal mucosal ulcerations, there is no mention of granulomatous inflammation, which is a hallmark of GPA.
* **No mention of subglottic stenosis**: Subglottic stenosis is a common feature of GPA, particularly in patients with long-standing disease. The absence of this finding does not rule out GPA, but it is a notable omission.
* **Mild left shift on WBC count**: While the patient has a mild left shift, a more pronounced left shift would be expected in GPA, particularly given the patient's c-ANCA positivity and renal involvement.
* **No mention of orbital or ocular involvement**: GPA can involve the orbits and eyes, leading to symptoms such as proptosis, diplopia, or conjunctivitis. The absence of these findings does not rule out GPA, but it is a notable omission.

**2. Microscopic Polyangiitis (MPA)**

* **c-ANCA positivity**: As mentioned earlier, MPA is typically associated with p-ANCA, not c-ANCA. The patient's c-ANCA positivity makes MPA a less likely diagnosis.
* **Lack of eosinophilia**: While not a universal feature of MPA, eosinophilia can be present in some cases. The absence of eosinophilia in this patient does not rule out MPA, but it is a notable omission.
* **No mention of gastrointestinal involvement**: MPA can involve the gastrointestinal tract, leading to symptoms such as abdominal pain, diarrhea, or gastrointestinal bleeding. The absence of these findings does not rule out MPA, but it is a notable omission.
* **Renal involvement is not as severe as expected**: While the patient has renal involvement, the severity of the renal disease is not as pronounced as would be expected in MPA, particularly given the patient's age and lack of other comorbidities.

**3. Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)**

* **No history of asthma**: Churg-Strauss Syndrome is typically associated with a history of asthma, which is not present in this patient.
* **No eosinophilia**: Eosinophilia is a hallmark of Churg-Strauss Syndrome, and the absence of this finding makes the diagnosis less likely.
* **No mention of neuropathy**: Churg-Strauss Syndrome can involve the peripheral nerves, leading to symptoms such as neuropathic pain, numbness, or weakness. The absence of these findings does not rule out Churg-Strauss Syndrome, but it is a notable omission.
* **c-ANCA positivity**: While c-ANCA can be present in Churg-Strauss Syndrome, it is not as common as p-ANCA or ANCA negativity. The patient's c-ANCA positivity makes GPA a more likely diagnosis.","Based on the patient's symptoms, laboratory results, and physical examination, the final diagnosis is:

**Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

The patient's presentation is consistent with GPA, including:

* Upper and lower respiratory tract involvement (sinus congestion, bloody nasal discharge, hemoptysis)
* Renal involvement (elevated serum creatinine, proteinuria with RBC casts)
* Systemic symptoms (unintentional weight loss, fatigue, joint pain)
* c-ANCA positivity, which is a strong indicator of GPA

The patient's symptoms and laboratory results are consistent with the American College of Rheumatology (ACR) criteria for GPA, which include:

* Nasal or oral inflammation
* Abnormal chest radiograph (multiple nodular lung infiltrates and cavities)
* Hematuria or red blood cell casts in the urine
* Granulomatous inflammation on biopsy (not present in this case, but not required for diagnosis)

The patient's c-ANCA positivity, renal involvement, and systemic symptoms make GPA the most likely diagnosis. The patient's lack of granulomatous inflammation on physical exam and no mention of subglottic stenosis or orbital/ocular involvement do not rule out GPA, as these findings are not universal in all patients with the disease.

Treatment for GPA typically involves immunosuppressive therapy, such as cyclophosphamide or rituximab, in combination with glucocorticoids. The patient's treatment plan should be individualized based on the severity of their disease and their response to therapy.","Based on the final diagnosis of Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA), the following additional steps should be taken:

1. **Confirmatory testing**: While the patient's c-ANCA positivity and clinical presentation are highly suggestive of GPA, a confirmatory test such as a biopsy of the affected tissue (e.g. kidney or lung) may be necessary to confirm the diagnosis.
2. **Imaging studies**: Additional imaging studies such as a chest CT scan or MRI may be necessary to fully evaluate the extent of the disease and to monitor for any potential complications.
3. **Laboratory tests**: Regular laboratory tests, including complete blood counts, electrolyte panels, and renal function tests, should be performed to monitor the patient's response to treatment and to detect any potential side effects.
4. **Ophthalmologic evaluation**: GPA can affect the eyes, so an ophthalmologic evaluation should be performed to assess for any potential eye involvement.
5. **ENT evaluation**: GPA can also affect the ears, nose, and throat, so an ENT evaluation should be performed to assess for any potential involvement in these areas.
6. **Pulmonary function tests**: Pulmonary function tests, such as spirometry and diffusion capacity, should be performed to assess for any potential lung involvement.
7. **Cardiac evaluation**: GPA can increase the risk of cardiovascular disease, so a cardiac evaluation, including an electrocardiogram and echocardiogram, should be performed to assess for any potential cardiac involvement.
8. **Treatment initiation**: Treatment for GPA should be initiated as soon as possible, and may include immunosuppressive therapy, such as cyclophosphamide or rituximab, in combination with glucocorticoids.
9. **Monitoring for complications**: The patient should be closely monitored for potential complications of GPA, such as renal failure, respiratory failure, and cardiovascular disease.
10. **Referral to a specialist**: The patient should be referred to a specialist, such as a rheumatologist or nephrologist, who has experience in managing GPA.

In terms of specific treatment, the following may be considered:

* **Induction therapy**: Cyclophosphamide or rituximab may be used as induction therapy to rapidly control the disease.
* **Maintenance therapy**: Azathioprine or methotrexate may be used as maintenance therapy to prevent relapse.
* **Glucocorticoids**: Glucocorticoids, such as prednisone, may be used to reduce inflammation and prevent relapse.
* **Plasmapheresis**: Plasmapheresis may be considered in patients with severe disease or those who are refractory to other treatments.

The patient's treatment plan should be individualized based on the severity of their disease and their response to therapy. Regular follow-up appointments with a healthcare provider are necessary to monitor the patient's response to treatment and to adjust the treatment plan as needed.","{""Score"":1,""Rationale"":""The answer includes Granulomatosis with Polyangiitis (Wegener's), which matches the first item in the rubric. The other two diagnoses (Microscopic Polyangiitis and Eosinophilic Granulomatosis with Polyangiitis) are not listed in the rubric, so they receive no points.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Granulomatosis with Polyangiitis (GPA) and includes the key features listed in the rubric, earning 2 points. It does not mention Rheumatoid Arthritis or Infectious Causes, so no points are awarded for those sections.""}","{""Score"":0,""Rationale"":""Student's answer discusses GPA, MPA, and EGPA, which do not match any of the three diagnoses (GPA, RA, Infectious Causes) listed in the rubric; therefore no points awarded.""}","{""Score"":2,""Rationale"":""Student answer correctly identifies Granulomatosis with Polyangiitis (GPA) and includes the key features listed in the high‑scoring example (sinus involvement, hemoptysis, joint swelling, c‑ANCA positivity, lung findings), thus meeting the rubric criteria for full credit.""}","{""Score"":2,""Rationale"":""The answer includes referral to a rheumatologist and mentions immunosuppressive therapy, matching rubric item 2 (2 points). It does not mention serial urine analysis or joint imaging, so those items receive no points.""}",7.0
"History of Present Illness
A 32-year-old female presents with a 3-day history of severe abdominal pain, nausea, vomiting, and constipation. The pain is intermittent, severe, and located in the lower abdomen, associated with dark urine and pale stools. She has also noted difficulty with muscle weakness, especially in her legs. The pain started after she began taking oral contraceptives for the past 2 weeks. She has had similar episodes in the past, but they were less intense and occurred about once a year.

  Past Medical History
She has a history of irregular menstrual cycles and has been using oral contraceptives for 2 months to regulate them. There is no significant family history of bleeding or liver disorders. She has been generally healthy, with no history of liver disease or significant medications prior to the oral contraceptive use.

  Physical Examination
VITALS: BP 120/75 mmHg, pulse 85/min, temperature 98.9°F. 
GEN: Appears in moderate distress, pale. 
CARDIAC: Regular rhythm, no murmurs. 
PULM: Clear to auscultation bilaterally. 
ABD: Diffuse tenderness to palpation in the lower abdomen with no rebound tenderness. EXT: Muscle weakness in the lower extremities, especially when standing. 
SKIN: No rashes, but urine is dark brown in color.

  Laboratory Results
Urine porphyrin levels are markedly elevated. Serum sodium is low at 130 mEq/L, and liver function tests are normal. Hemoglobin is 11.3 g/dL.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Acute Intermittent Porphyria (AIP)**: The patient's symptoms of severe abdominal pain, nausea, vomiting, constipation, and muscle weakness, particularly in the legs, are consistent with AIP. The elevated urine porphyrin levels also support this diagnosis. The recent introduction of oral contraceptives may have triggered an acute attack.
2. **Porphyria Cutanea Tarda (PCT)**: Although PCT typically presents with skin manifestations, the patient's elevated urine porphyrin levels and abdominal symptoms could suggest a diagnosis of PCT. However, the absence of skin lesions and the presence of acute abdominal symptoms make AIP a more likely diagnosis.
3. **Variegate Porphyria (VP)**: VP is another type of porphyria that can present with acute abdominal symptoms, neurological symptoms, and elevated urine porphyrin levels. The patient's symptoms, including muscle weakness and abdominal pain, could be consistent with VP, although the absence of skin lesions and the specific pattern of porphyrin elevation would need to be further evaluated to confirm this diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Acute Intermittent Porphyria (AIP)**

* **Severe abdominal pain**: AIP is characterized by recurrent episodes of severe abdominal pain, which is consistent with the patient's symptoms.
* **Elevated urine porphyrin levels**: The patient's urine porphyrin levels are markedly elevated, which is a hallmark of AIP.
* **Neurological symptoms**: The patient's muscle weakness, particularly in the legs, is consistent with the neurological symptoms seen in AIP.
* **Triggered by oral contraceptives**: The patient's symptoms started after she began taking oral contraceptives, which are known to be a potential trigger for AIP attacks.
* **Absence of skin lesions**: AIP typically does not present with skin lesions, which is consistent with the patient's physical examination.

**2. Porphyria Cutanea Tarda (PCT)**

* **Elevated urine porphyrin levels**: While the patient's urine porphyrin levels are elevated, PCT typically presents with a different pattern of porphyrin elevation.
* **Potential for hormonal triggers**: Oral contraceptives can be a trigger for PCT, although this is less common than in AIP.
* **However, lack of skin lesions**: The patient does not have any skin lesions, which are a characteristic feature of PCT. This makes PCT a less likely diagnosis.

**3. Variegate Porphyria (VP)**

* **Elevated urine porphyrin levels**: The patient's urine porphyrin levels are elevated, which is consistent with VP.
* **Acute abdominal symptoms**: VP can present with acute abdominal symptoms, which is consistent with the patient's presentation.
* **Neurological symptoms**: The patient's muscle weakness is consistent with the neurological symptoms seen in VP.
* **Potential for hormonal triggers**: Oral contraceptives can be a trigger for VP, although this is less common than in AIP.
* **However, lack of skin lesions**: The patient does not have any skin lesions, which can be a feature of VP. This makes VP a less likely diagnosis, although it is still possible.

Overall, the patient's symptoms and laboratory results are most consistent with AIP, although VP is still a possible diagnosis. PCT is less likely due to the absence of skin lesions.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Acute Intermittent Porphyria (AIP)**

* **Normal liver function tests**: AIP can sometimes present with mild elevations in liver function tests, but the patient's liver function tests are normal.
* **No history of neurological symptoms**: While the patient presents with muscle weakness, there is no history of neurological symptoms such as seizures, psychosis, or peripheral neuropathy, which can be seen in AIP.
* **No tachycardia or hypertension**: AIP attacks can be associated with tachycardia and hypertension, but the patient's vital signs are within normal limits.
* **Normal hemoglobin level**: While the patient's hemoglobin is slightly low, it is not as low as might be expected in AIP, where hemolysis can occur.

**2. Porphyria Cutanea Tarda (PCT)**

* **Absence of skin lesions**: PCT is characterized by the presence of skin lesions, such as blisters, erosions, and hypertrichosis, which are not present in this patient.
* **Acute abdominal symptoms**: PCT typically does not present with acute abdominal symptoms, which are a prominent feature of this patient's presentation.
* **Normal liver function tests**: PCT is often associated with liver disease, but the patient's liver function tests are normal.
* **No history of liver disease**: PCT is often associated with a history of liver disease, but the patient has no such history.

**3. Variegate Porphyria (VP)**

* **No skin lesions**: While VP can present without skin lesions, they are a common feature of the disease, and their absence makes the diagnosis less likely.
* **Normal liver function tests**: VP can be associated with mild elevations in liver function tests, but the patient's liver function tests are normal.
* **No history of photosensitivity**: VP can cause photosensitivity, but the patient does not report any such symptoms.
* **No family history**: VP is often inherited in an autosomal dominant pattern, and a family history of the disease might be expected, but the patient reports no such history.

Overall, while each of the possible diagnoses has some opposing findings, AIP remains the most likely diagnosis based on the patient's symptoms and laboratory results.","Based on the patient's symptoms, laboratory results, and physical examination, the final diagnosis is:

**Acute Intermittent Porphyria (AIP)**

The diagnosis of AIP is supported by the following:

* Severe abdominal pain, nausea, vomiting, and constipation, which are characteristic symptoms of AIP
* Elevated urine porphyrin levels, which are a hallmark of AIP
* Muscle weakness, particularly in the legs, which is a common neurological symptom of AIP
* Recent introduction of oral contraceptives, which can trigger an AIP attack
* Absence of skin lesions, which is consistent with AIP (as opposed to other types of porphyria, such as PCT or VP)

The patient's laboratory results, including the elevated urine porphyrin levels and normal liver function tests, also support the diagnosis of AIP.

**Treatment and Management:**

The patient should be managed with:

* Withdrawal of oral contraceptives, which may have triggered the AIP attack
* Intravenous glucose and hydration to help manage symptoms
* Pain management with opioids or other analgesics
* Monitoring of urine porphyrin levels and clinical symptoms to assess response to treatment
* Consideration of heme arginate or other specific therapies for AIP, if available and indicated

**Long-term Management:**

The patient should be counseled on the risks and benefits of hormonal therapies, such as oral contraceptives, and alternative methods of contraception should be discussed. The patient should also be educated on the signs and symptoms of an AIP attack and how to manage them, as well as the importance of regular follow-up with a healthcare provider to monitor for any changes in symptoms or laboratory results.","Based on the diagnosis of Acute Intermittent Porphyria (AIP), the following additional steps should be taken:

1. **Confirmatory testing**: Perform additional laboratory tests to confirm the diagnosis of AIP, such as:
	* Measurement of erythrocyte porphobilinogen deaminase (PBGD) activity
	* Urine porphyrin profile to identify the specific type of porphyrin elevation
	* Genetic testing to identify the underlying mutation in the HMBS gene
2. **Family screening**: Screen first-degree relatives (parents, siblings, and children) for AIP, as it is an autosomal dominant disorder:
	* Measure urine porphyrin levels and PBGD activity in family members
	* Offer genetic testing to family members if the patient's mutation is identified
3. **Hormonal therapy management**: Manage hormonal therapies, such as oral contraceptives, carefully:
	* Consider alternative methods of contraception, such as intrauterine devices (IUDs) or barrier methods
	* Monitor urine porphyrin levels and clinical symptoms closely if hormonal therapies are continued
4. **Pain management**: Develop a pain management plan to help the patient manage acute attacks:
	* Prescribe opioids or other analgesics as needed
	* Consider alternative pain management strategies, such as acupuncture or relaxation techniques
5. **Nutritional counseling**: Provide nutritional counseling to help the patient manage symptoms:
	* Recommend a high-carbohydrate diet to help reduce porphyrin production
	* Encourage the patient to avoid fasting or severe calorie restriction
6. **Psychological support**: Offer psychological support to help the patient cope with the diagnosis and manage stress:
	* Refer the patient to a mental health professional, such as a psychologist or therapist
	* Encourage the patient to join a support group for individuals with AIP
7. **Regular follow-up**: Schedule regular follow-up appointments to monitor the patient's condition:
	* Measure urine porphyrin levels and PBGD activity regularly
	* Assess the patient's symptoms and adjust the treatment plan as needed
8. **Education and resources**: Provide the patient with educational resources and information about AIP:
	* Refer the patient to reputable online resources, such as the American Porphyria Foundation
	* Encourage the patient to ask questions and seek support from healthcare providers and support groups.","{""Score"":0.5,""Rationale"":""The answer includes Acute Intermittent Porphyria (AIP), which matches one of the three required diagnoses in the rubric. The other two diagnoses (Porphyria Cutanea Tarda and Variegate Porphyria) do not match the rubric items (Cholecystitis/Gallstones and irritable Bowel Syndrome), so no points are awarded for them.""}","{""Score"":1,""Rationale"":""The answer correctly identifies Acute Intermittent Porphyria and includes several rubric‑listed features (severe abdominal pain, muscle weakness, oral‑contraceptive trigger, elevated urine porphyrin). However, it does not mention the other two diagnoses (Cholecystitis/Gallstones and IBS) required for full credit, so only 1 of the 3 possible points is awarded.""}","{""Score"":0,""Rationale"":""The answer does not match any of the rubric's listed concepts. It provides opposing findings for AIP, which contradicts the rubric's statement of no opposing findings, and omits Gallstones/Cholecystitis and IBS entirely. Hence no points awarded.""}","{""Score"":14.5,""Rationale"":""The answer correctly identifies Acute Intermittent Porphyria (AIP) and cites abdominal pain, muscle weakness, and elevated urine porphyrins, matching the high‑scoring example.""}","{""Score"":1,""Rationale"":""The answer includes genetic testing, matching rubric item 1. It does not mention IV glucose or hematin infusion, nor explicitly state discontinuation of oral contraceptives, so those items receive no points.""}",17.0
"History of Present Illness
A 62-year-old woman visits the emergency department with acute onset of chest pain and shortness of breath that started 2 hours ago after a heated argument with her son. She describes the pain as crushing and radiating to her left arm. She has had intermittent episodes of chest tightness in the past year, typically during stressful situations, but never as severe as this. She denies nausea, vomiting, or syncope.

  Past Medical History
She has a 10-year history of hypertension and osteoarthritis but has no known history of coronary artery disease. She is on lisinopril and acetaminophen. She has no family history of cardiac conditions or sudden death. She denies smoking or alcohol use.

  Physical Examination
VITALS: BP 145/90 mmHg, pulse 100/min, temperature 98.4°F. 
GEN: Mildly anxious, diaphoretic. 
CARDIAC: Tachycardic, no murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Non-tender, no hepatosplenomegaly. 
EXT: No cyanosis or edema. 
SKIN: Warm and dry.

  Laboratory Results
Troponin I is elevated at 3.5 ng/mL. Serum brain natriuretic peptide (BNP) is 280 pg/mL. Electrocardiogram (ECG) shows ST-segment elevation in leads V2-V4. ",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Acute Myocardial Infarction (MI)**: The patient's symptoms of crushing chest pain radiating to the left arm, shortness of breath, and elevated troponin I level are consistent with an acute MI. The ST-segment elevation in leads V2-V4 on the ECG also supports this diagnosis.
2. **Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**: The patient's symptoms started after a heated argument, which could be a stress trigger for this condition. The elevated troponin I level and ST-segment elevation on the ECG could also be seen in Takotsubo cardiomyopathy.
3. **Acute Coronary Syndrome (ACS) with possible Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA)**: The patient's symptoms and elevated troponin I level suggest an ACS, but the absence of a known history of coronary artery disease and the fact that the pain started after a stressful event could suggest a non-obstructive coronary artery disease, such as MINOCA.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Acute Myocardial Infarction (MI)**

* Supporting findings:
	+ Elevated troponin I level (3.5 ng/mL), which is a specific marker for myocardial damage
	+ ST-segment elevation in leads V2-V4 on the ECG, which is a classic sign of an acute MI
	+ Crushing chest pain radiating to the left arm, which is a typical symptom of an MI
* Risk factors:
	+ Hypertension (10-year history), which is a major risk factor for coronary artery disease and MI
	+ Age (62 years), which increases the risk of MI
	+ Stressful event (heated argument), which can trigger an MI in susceptible individuals

**2. Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**

* Supporting findings:
	+ Acute onset of symptoms after a stressful event (heated argument), which is a classic trigger for Takotsubo cardiomyopathy
	+ Elevated troponin I level (3.5 ng/mL), which can be seen in Takotsubo cardiomyopathy
	+ ST-segment elevation on the ECG, which can be seen in Takotsubo cardiomyopathy
* Risk factors:
	+ Female sex, which is a risk factor for Takotsubo cardiomyopathy (women are more commonly affected than men)
	+ Age (62 years), which is within the typical age range for Takotsubo cardiomyopathy
	+ Stressful event (heated argument), which is a common trigger for Takotsubo cardiomyopathy

**3. Acute Coronary Syndrome (ACS) with possible Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA)**

* Supporting findings:
	+ Elevated troponin I level (3.5 ng/mL), which suggests myocardial damage
	+ Chest pain and shortness of breath, which are typical symptoms of ACS
	+ ST-segment elevation on the ECG, which can be seen in ACS
* Risk factors:
	+ Hypertension (10-year history), which is a risk factor for coronary artery disease and ACS
	+ Age (62 years), which increases the risk of ACS
	+ Stressful event (heated argument), which can trigger an ACS in susceptible individuals
	+ Absence of a known history of coronary artery disease, which could suggest a non-obstructive coronary artery disease such as MINOCA.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Acute Myocardial Infarction (MI)**

* Opposing findings:
	+ The patient's symptoms started after a stressful event, which is not a typical trigger for an MI (although it's not unheard of)
	+ The patient has no known history of coronary artery disease, which is a major risk factor for MI
	+ The physical examination does not show any signs of heart failure, such as jugular venous distension or pedal edema, which can be seen in large MIs
* Expected but not present findings:
	+ Q-waves on the ECG, which are often seen in MIs, but are not present in this case
	+ More significant ST-segment elevation on the ECG, which is often seen in larger MIs
	+ Elevated creatine kinase (CK) or CK-MB levels, which are often seen in MIs, but were not reported in this case

**2. Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**

* Opposing findings:
	+ The patient's symptoms are more typical of an MI, with crushing chest pain radiating to the left arm, which is not always seen in Takotsubo cardiomyopathy
	+ The patient has a history of hypertension, which is not a typical risk factor for Takotsubo cardiomyopathy
	+ The ECG shows ST-segment elevation in leads V2-V4, which is not always seen in Takotsubo cardiomyopathy (although it can be)
* Expected but not present findings:
	+ More significant ECG changes, such as deep T-wave inversions or QT prolongation, which are often seen in Takotsubo cardiomyopathy
	+ Echocardiogram showing apical ballooning or hypokinesis, which is a hallmark of Takotsubo cardiomyopathy, but was not reported in this case
	+ More significant elevation of BNP levels, which are often seen in Takotsubo cardiomyopathy, but the level of 280 pg/mL is not extremely high

**3. Acute Coronary Syndrome (ACS) with possible Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA)**

* Opposing findings:
	+ The patient's symptoms are more typical of an MI, with crushing chest pain radiating to the left arm, which is not always seen in MINOCA
	+ The patient has no known history of coronary artery disease, which is not always a requirement for MINOCA, but is less common
	+ The ECG shows ST-segment elevation in leads V2-V4, which is not always seen in MINOCA (although it can be)
* Expected but not present findings:
	+ More significant elevation of troponin I levels, which are often seen in MINOCA, but the level of 3.5 ng/mL is not extremely high
	+ Echocardiogram showing wall motion abnormalities, which are often seen in MINOCA, but was not reported in this case
	+ Coronary angiogram showing non-obstructive coronary arteries, which is a hallmark of MINOCA, but was not reported in this case","Based on the patient's symptoms, physical examination, laboratory results, and ECG findings, the final diagnosis is:

**Acute Myocardial Infarction (MI)**

The patient's symptoms of crushing chest pain radiating to the left arm, shortness of breath, and diaphoresis, which started after a stressful event, are consistent with an acute MI. The elevated troponin I level (3.5 ng/mL) and ST-segment elevation in leads V2-V4 on the ECG are also consistent with an acute MI. While the patient has no known history of coronary artery disease, the presence of hypertension and the patient's age (62 years) increase the risk of coronary artery disease and MI.

The diagnosis of MI is further supported by the fact that the patient's symptoms and ECG changes are more typical of an MI than of other possible diagnoses, such as Takotsubo cardiomyopathy or MINOCA. Additionally, the patient's elevated troponin I level and ST-segment elevation on the ECG are more consistent with an MI than with other possible diagnoses.

**Type of MI:** Based on the ECG findings, the MI is likely a **ST-Elevation Myocardial Infarction (STEMI)**.

**Next steps:**

* The patient should be immediately referred to the catheterization laboratory for coronary angiography and possible percutaneous coronary intervention (PCI) to restore blood flow to the affected coronary artery.
* The patient should also receive aspirin, beta blockers, and other medications as indicated to reduce the risk of further cardiac complications.
* The patient should be closely monitored in the intensive care unit (ICU) for any signs of complications, such as heart failure or arrhythmias.","Based on the final diagnosis of Acute Myocardial Infarction (MI), the following additional steps should be taken:

**Immediate Steps:**

1. **Administer oxygen**: Provide oxygen therapy to help increase oxygenation of the heart muscle.
2. **Initiate pain management**: Administer morphine or other pain medications to help alleviate chest pain and discomfort.
3. **Start antiplatelet therapy**: Administer aspirin and other antiplatelet medications, such as clopidogrel or prasugrel, to help prevent further clotting.
4. **Initiate beta blocker therapy**: Administer beta blockers, such as metoprolol or atenolol, to help reduce heart rate and blood pressure.
5. **Activate the catheterization laboratory**: Notify the catheterization laboratory to prepare for emergency coronary angiography and possible percutaneous coronary intervention (PCI).

**Diagnostic Steps:**

1. **Coronary angiography**: Perform emergency coronary angiography to visualize the coronary arteries and identify the location and extent of the blockage.
2. **Echocardiogram**: Perform an echocardiogram to assess left ventricular function and identify any wall motion abnormalities.
3. **Cardiac biomarkers**: Repeat troponin I levels and other cardiac biomarkers to monitor the extent of cardiac damage.
4. **Electrocardiogram (ECG) monitoring**: Continuously monitor the patient's ECG for any signs of arrhythmias or further ischemia.

**Therapeutic Steps:**

1. **Percutaneous coronary intervention (PCI)**: Perform PCI to restore blood flow to the affected coronary artery.
2. **Thrombolytic therapy**: Consider administering thrombolytic therapy, such as tPA, if PCI is not available or if the patient has a contraindication to PCI.
3. **Anticoagulation therapy**: Administer anticoagulation therapy, such as heparin or bivalirudin, to help prevent further clotting.
4. **Statin therapy**: Initiate statin therapy to help reduce cholesterol levels and prevent further cardiac events.

**Monitoring and Follow-up:**

1. **Intensive care unit (ICU) admission**: Admit the patient to the ICU for close monitoring and management.
2. **Cardiac monitoring**: Continuously monitor the patient's cardiac rhythm and blood pressure.
3. **Serial troponin levels**: Repeat troponin levels to monitor the extent of cardiac damage.
4. **Follow-up echocardiogram**: Perform a follow-up echocardiogram to assess left ventricular function and identify any wall motion abnormalities.
5. **Cardiac rehabilitation**: Refer the patient to cardiac rehabilitation to help improve cardiovascular health and reduce the risk of further cardiac events.","{""Score"":2,""Rationale"":""The answer includes Acute Myocardial Infarction and Takotsubo Cardiomyopathy, matching two rubric items. It does not list Unstable Angina, so only 2 of 3 points are earned.""}","{""Score"":4,""Rationale"":""Student correctly identified and described Takotsubo Cardiomyopathy and Acute Myocardial Infarction with matching key features from the rubric, earning 2 points each. Unstable Angina was not mentioned, so no points were awarded for that component.""}","{""Score"":0,""Rationale"":""The answer does not include any of the specific opposing findings or expected absent findings listed in the rubric for Takotsubo cardiomyopathy, acute myocardial infarction, or unstable angina; therefore no points are awarded.""}","{""Score"":2,""Rationale"":""The student identified the diagnosis as an ST-Elevation Myocardial Infarction (STEMI), which aligns with the rubric’s required answer of Acute Coronary Syndrome (Anterior STEMI). The supporting details (ST-elevation in V2-V4, troponin elevation, symptoms) also match the rubric’s rationale.""}","{""Score"":2,""Rationale"":""Student mentions a follow-up echocardiogram, matching item 2, but does not include ACE inhibitors, psychological support, or referral to a cardiologist, so only 2 of the 6 possible points are earned.""}",10.0
"History of Present Illness
A 65-year-old male with a history of type 2 diabetes and hypertension presents with a 2-hour history of crushing chest pain radiating to his left arm. He describes the pain as severe and constant, beginning after he climbed a flight of stairs. He is also feeling nauseated and sweaty. He is unable to recall a prior history of similar symptoms. He denies shortness of breath or palpitations but admits to feeling unusually fatigued for the last week.

  Past Medical History
Type 2 diabetes mellitus for 15 years, hypertension for 12 years, and hyperlipidemia. He is on metformin and a statin. He has no history of coronary artery disease or previous myocardial infarctions. He is a smoker (30 pack-years) and drinks alcohol occasionally. Family history is significant for cardiovascular disease, with both parents having had myocardial infarctions in their 50s

  Physical Examination
VITALS: BP 160/90 mmHg, pulse 110 bpm, temperature 98.5°F. 
GEN: Anxious and diaphoretic, in moderate distress due to chest pain. 
CARDIAC: Tachycardic, regular rhythm
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender, no hepatosplenomegaly. 
MSK: No tenderness or joint swelling. 
EXT: No edema. 
SKIN: Diaphoretic, cool extremities.

  Laboratory Results
Troponin I: 3.2 ng/mL (elevated). CBC: Normal. Serum glucose: 180 mg/dL (elevated).",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Acute Myocardial Infarction (MI)**: The patient's symptoms of crushing chest pain radiating to the left arm, nausea, sweating, and elevated troponin I level are consistent with an acute MI.
2. **Unstable Angina**: The patient's chest pain and electrocardiogram (ECG) findings (although not provided) may also suggest unstable angina, which is a condition where the heart muscle does not receive enough oxygen-rich blood.
3. **Acute Coronary Syndrome (ACS)**: This is a broader diagnosis that encompasses both MI and unstable angina, and is characterized by a sudden reduction in blood flow to the heart muscle, which can cause chest pain and other symptoms.

Note: These diagnoses are not mutually exclusive, and the patient's presentation suggests a high likelihood of an acute coronary event. Further evaluation, including ECG and cardiac catheterization, would be necessary to confirm the diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Acute Myocardial Infarction (MI)**

* Supporting findings:
	+ Elevated troponin I level (3.2 ng/mL), which is a specific marker for cardiac muscle damage
	+ Crushing chest pain radiating to the left arm, which is a classic symptom of MI
	+ Nausea and sweating, which are common accompanying symptoms of MI
	+ Tachycardia (pulse 110 bpm) and hypertension (BP 160/90 mmHg), which can be seen in the setting of MI
* Supporting risk factors:
	+ History of hypertension, hyperlipidemia, and type 2 diabetes mellitus, which are all risk factors for coronary artery disease and MI
	+ 30 pack-year smoking history, which significantly increases the risk of coronary artery disease and MI
	+ Family history of cardiovascular disease, with both parents having had myocardial infarctions in their 50s

**2. Unstable Angina**

* Supporting findings:
	+ Chest pain that is severe and constant, which can be seen in unstable angina
	+ Recent onset of fatigue, which can be a symptom of reduced cardiac output
	+ Tachycardia (pulse 110 bpm) and hypertension (BP 160/90 mmHg), which can be seen in the setting of unstable angina
* Supporting risk factors:
	+ History of hypertension, hyperlipidemia, and type 2 diabetes mellitus, which are all risk factors for coronary artery disease and unstable angina
	+ 30 pack-year smoking history, which significantly increases the risk of coronary artery disease and unstable angina
	+ Family history of cardiovascular disease, with both parents having had myocardial infarctions in their 50s

**3. Acute Coronary Syndrome (ACS)**

* Supporting findings:
	+ Chest pain that is severe and constant, which is a hallmark symptom of ACS
	+ Elevated troponin I level (3.2 ng/mL), which suggests cardiac muscle damage
	+ Tachycardia (pulse 110 bpm) and hypertension (BP 160/90 mmHg), which can be seen in the setting of ACS
	+ Recent onset of fatigue, which can be a symptom of reduced cardiac output
* Supporting risk factors:
	+ History of hypertension, hyperlipidemia, and type 2 diabetes mellitus, which are all risk factors for coronary artery disease and ACS
	+ 30 pack-year smoking history, which significantly increases the risk of coronary artery disease and ACS
	+ Family history of cardiovascular disease, with both parents having had myocardial infarctions in their 50s

Note that the findings and risk factors for these diagnoses are not mutually exclusive, and the patient's presentation suggests a high likelihood of an acute coronary event. Further evaluation, including ECG and cardiac catheterization, would be necessary to confirm the diagnosis.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Acute Myocardial Infarction (MI)**

* Opposing findings:
	+ The patient's symptoms started after climbing a flight of stairs, which could suggest an exertional component to the chest pain, but the pain is described as severe and constant, which is more typical of MI.
	+ The patient's pulse is 110 bpm, but the blood pressure is 160/90 mmHg, which is not typically seen in cardiogenic shock, a common complication of MI.
	+ The patient's lungs are clear to auscultation, which suggests that there is no significant pulmonary edema, a common finding in MI.
* Expected but not present findings:
	+ Shortness of breath or dyspnea, which is a common symptom of MI, especially if there is associated pulmonary edema.
	+ Palpitations or arrhythmias, which can occur in the setting of MI due to cardiac irritability.
	+ Significant ECG changes, such as Q-waves or ST-segment elevation, which are often seen in MI (although the ECG is not provided).

**2. Unstable Angina**

* Opposing findings:
	+ The patient's troponin I level is elevated (3.2 ng/mL), which suggests cardiac muscle damage, which is more typical of MI than unstable angina.
	+ The patient's chest pain is described as severe and constant, which is more typical of MI than unstable angina, which often presents with more variable or intermittent pain.
	+ The patient's symptoms started after climbing a flight of stairs, which could suggest an exertional component to the chest pain, but the pain is described as severe and constant, which is more typical of MI.
* Expected but not present findings:
	+ ECG changes, such as ST-segment depression or T-wave inversion, which are often seen in unstable angina (although the ECG is not provided).
	+ A history of prior angina or coronary artery disease, which would increase the likelihood of unstable angina.

**3. Acute Coronary Syndrome (ACS)**

* Opposing findings:
	+ None of the findings strongly oppose the diagnosis of ACS, as the patient's presentation is consistent with an acute coronary event.
* Expected but not present findings:
	+ Significant ECG changes, such as ST-segment elevation or depression, which are often seen in ACS (although the ECG is not provided).
	+ A history of prior coronary artery disease or angina, which would increase the likelihood of ACS.
	+ Shortness of breath or dyspnea, which can occur in the setting of ACS, especially if there is associated pulmonary edema.

Note that the absence of certain findings does not necessarily rule out a diagnosis, and the patient's presentation suggests a high likelihood of an acute coronary event. Further evaluation, including ECG and cardiac catheterization, would be necessary to confirm the diagnosis.","Based on the patient's presentation, history, and laboratory results, the final diagnosis is:

**Acute Myocardial Infarction (MI)**

The diagnosis of MI is supported by the following:

* The patient's symptoms of crushing chest pain radiating to the left arm, nausea, and sweating, which are classic symptoms of MI.
* The elevated troponin I level (3.2 ng/mL), which is a specific marker for cardiac muscle damage.
* The patient's history of hypertension, hyperlipidemia, and type 2 diabetes mellitus, which are all risk factors for coronary artery disease and MI.
* The patient's 30 pack-year smoking history, which significantly increases the risk of coronary artery disease and MI.
* The family history of cardiovascular disease, with both parents having had myocardial infarctions in their 50s.

The diagnosis of MI is further supported by the absence of alternative explanations for the patient's symptoms and laboratory results. While unstable angina and acute coronary syndrome are possible diagnoses, the patient's presentation and laboratory results are more consistent with MI.

**Type of MI:**

Based on the patient's symptoms and laboratory results, the type of MI is likely a **Non-ST-Elevation Myocardial Infarction (NSTEMI)**. This is because the patient's symptoms are consistent with a coronary artery occlusion, but the ECG is not provided, and the troponin I level is elevated, which suggests cardiac muscle damage.

**Next Steps:**

The next steps in management would include:

* Immediate initiation of aspirin and other antiplatelet therapy to reduce the risk of further coronary occlusion.
* Administration of beta blockers and nitrates to reduce myocardial oxygen demand and alleviate symptoms.
* Consideration of thrombolytic therapy or primary percutaneous coronary intervention (PCI) to restore coronary blood flow.
* Close monitoring of the patient's vital signs, ECG, and laboratory results to assess for any signs of complications or worsening of the condition.
* Initiation of statin therapy to reduce the risk of further cardiovascular events.
* Counseling on lifestyle modifications, including smoking cessation, diet, and exercise, to reduce the risk of future cardiovascular events.","Based on the patient's presentation and diagnosis of Acute Myocardial Infarction (MI), the following additional steps should be taken:

**Immediate Steps:**

1. **Activate the cardiac catheterization lab**: Prepare for potential primary percutaneous coronary intervention (PCI) or coronary angiography to assess the coronary arteries and identify the culprit lesion.
2. **Administer oxygen**: Provide supplemental oxygen to help increase oxygen delivery to the myocardium and reduce ischemia.
3. **Monitor vital signs**: Continuously monitor the patient's vital signs, including blood pressure, heart rate, and oxygen saturation, to quickly identify any signs of instability or complications.
4. **Establish intravenous access**: Insert two large-bore intravenous lines to facilitate the administration of medications and fluids.
5. **Send additional laboratory tests**: Send additional laboratory tests, including complete blood count (CBC), electrolyte panel, and liver function tests, to assess for any underlying conditions that may be contributing to the patient's presentation.

**Medications:**

1. **Aspirin**: Administer aspirin 162-325 mg orally or intravenously to reduce platelet aggregation and prevent further coronary occlusion.
2. **Beta blockers**: Administer beta blockers, such as metoprolol, to reduce myocardial oxygen demand and alleviate symptoms.
3. **Nitrates**: Administer nitrates, such as nitroglycerin, to reduce myocardial oxygen demand and alleviate symptoms.
4. **Anticoagulation**: Administer anticoagulation therapy, such as heparin or enoxaparin, to prevent further coronary occlusion and reduce the risk of complications.
5. **Antiplatelet therapy**: Administer antiplatelet therapy, such as clopidogrel or prasugrel, to reduce platelet aggregation and prevent further coronary occlusion.

**Imaging and Diagnostic Tests:**

1. **Electrocardiogram (ECG)**: Perform a 12-lead ECG to assess for any signs of ischemia or infarction.
2. **Echocardiogram**: Perform an echocardiogram to assess left ventricular function and identify any signs of wall motion abnormalities.
3. **Coronary angiography**: Perform coronary angiography to assess the coronary arteries and identify the culprit lesion.
4. **Cardiac biomarkers**: Send cardiac biomarkers, such as troponin and CK-MB, to assess for any signs of cardiac damage.

**Consultations:**

1. **Cardiology consultation**: Consult with a cardiologist to discuss the patient's management and potential interventions.
2. **Interventional cardiology consultation**: Consult with an interventional cardiologist to discuss the potential for primary PCI or coronary angiography.

**Other:**

1. **Pain management**: Provide adequate pain management to alleviate the patient's symptoms and reduce anxiety.
2. **Anxiety reduction**: Provide anxiety reduction techniques, such as reassurance and relaxation, to help reduce the patient's stress and anxiety.
3. **Family support**: Provide support and education to the patient's family members to help them understand the patient's condition and management.","{""Score"":2,""Rationale"":""The answer includes Acute Myocardial Infarction and Unstable Angina, which match two items in the rubric. The third listed diagnosis, Acute Coronary Syndrome, is not in the rubric (GERD is missing), so only 2 of the 3 possible points are awarded.""}","{""Score"":4,""Rationale"":""The answer correctly includes Acute Myocardial Infarction and Unstable Angina with appropriate supporting findings and risk factors, matching the rubric (2 points each). However, it does not address Gastroesophageal Reflux Disease as required and instead adds Acute Coronary Syndrome, which is not in the rubric, resulting in loss of the remaining 2 points.""}","{""Score"":2,""Rationale"":""The answer correctly notes troponin elevation as opposing unstable angina, matching a concept in the rubric, but fails to provide the required 'no opposing findings' for MI and does not address GERD at all, resulting in only 2 of the possible 6 points.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Acute Myocardial Infarction (MI) and provides matching concepts from the rubric: crushing chest pain, elevated troponin, and significant cardiac risk factors. These align with the high‑scoring example, satisfying the rubric criteria for full credit.""}","{""Score"":6,""Rationale"":""Student mentions aspirin and heparin, nitroglycerin, and cardiac catheterization/coronary angiography, matching all three rubric items (2 points each).""}",16.0
"History of Present Illness
A 60-year-old male with a recent history of hip replacement surgery 2 weeks ago presents with sudden onset of shortness of breath and pleuritic chest pain. The pain is sharp and worsens with deep breathing or coughing. He has been feeling progressively more breathless, even while at rest, and also reports a mild cough. He denies fever or hemoptysis but admits to feeling fatigued and dizzy on exertion. He has not been able to move around much post-surgery, and has been primarily confined to bed. He has no known history of deep vein thrombosis (DVT).

  Past Medical History
He has a history of osteoarthritis, for which he underwent the recent hip replacement. He has no known history of cardiovascular or respiratory disease. No significant family history of pulmonary embolism or clotting disorders. He is a non-smoker and does not drink alcohol.

  Physical Examination
VITALS: BP 130/85 mmHg, pulse 110 bpm, temperature 98.7°F, respiratory rate 22/min. GEN: Mildly anxious, appears in moderate distress due to breathing difficulties. CARDIAC: Tachycardic, regular rhythm, no murmurs. 
PULM: Tachypneic, decreased breath sounds at the right base, no wheezing. 
ABD: Soft, non-tender. 
MSK: Limited movement of the right hip due to recent surgery. 
EXT: Mild swelling in the right lower leg, no redness or warmth. 
SKIN: No rashes, warm extremities.

  Laboratory Results
D-dimer: 8.5 µg/mL (elevated). Chest CT angiogram: Acute pulmonary embolism in the right lower lobe pulmonary artery. ABG: pO2 70 mmHg, pCO2 35 mmHg.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and test results, here are 3 possible diagnoses:

1. **Pulmonary Embolism (PE)**: The patient's symptoms of sudden onset shortness of breath, pleuritic chest pain, and elevated D-dimer, along with the chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery, strongly support this diagnosis.
2. **Deep Vein Thrombosis (DVT)**: The patient's recent history of hip replacement surgery, immobility, and mild swelling in the right lower leg suggest a possible DVT, which could be a source of the pulmonary embolism.
3. **Postoperative Atelectasis or Pneumonia**: Although less likely given the chest CT angiogram results, the patient's recent surgery, immobility, and symptoms of shortness of breath and pleuritic chest pain could also be consistent with postoperative atelectasis or pneumonia, particularly if the patient has developed a complication such as a lung collapse or infection.","Here are the findings and risk factors supporting each possible diagnosis:

**1. Pulmonary Embolism (PE)**

* Supporting findings:
	+ Sudden onset of shortness of breath and pleuritic chest pain
	+ Elevated D-dimer (8.5 µg/mL)
	+ Chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery
	+ Decreased breath sounds at the right base on physical examination
	+ Hypoxemia (pO2 70 mmHg) on ABG
* Risk factors:
	+ Recent hip replacement surgery, which increases the risk of venous thromboembolism (VTE)
	+ Immobility post-surgery, which increases the risk of VTE
	+ Age (60 years), which increases the risk of VTE

**2. Deep Vein Thrombosis (DVT)**

* Supporting findings:
	+ Mild swelling in the right lower leg
	+ Recent hip replacement surgery, which increases the risk of VTE
	+ Immobility post-surgery, which increases the risk of VTE
* Risk factors:
	+ Recent hip replacement surgery, which increases the risk of VTE
	+ Immobility post-surgery, which increases the risk of VTE
	+ Age (60 years), which increases the risk of VTE
	+ Note: While there is no known history of DVT, the patient's symptoms and risk factors suggest a possible DVT, which could be a source of the pulmonary embolism

**3. Postoperative Atelectasis or Pneumonia**

* Supporting findings:
	+ Recent hip replacement surgery, which increases the risk of postoperative pulmonary complications
	+ Immobility post-surgery, which increases the risk of atelectasis
	+ Shortness of breath and pleuritic chest pain
* Risk factors:
	+ Recent hip replacement surgery, which increases the risk of postoperative pulmonary complications
	+ Immobility post-surgery, which increases the risk of atelectasis
	+ Age (60 years), which increases the risk of postoperative pulmonary complications
	+ Note: However, the chest CT angiogram showing a pulmonary embolism and the lack of fever, cough, or other symptoms of infection make this diagnosis less likely.","Here are the findings opposing each possible diagnosis, or findings that were expected but not present:

**1. Pulmonary Embolism (PE)**

* Opposing findings:
	+ Normal blood pressure (130/85 mmHg) and lack of hypotension, which is often seen in large or massive PE
	+ Absence of hemoptysis, which can be a symptom of PE
	+ No signs of right heart strain on physical examination, such as a loud P2 or a tricuspid regurgitation murmur
* Expected but not present findings:
	+ Elevated troponin or BNP levels, which can be seen in PE due to right heart strain
	+ More significant hypoxemia or respiratory acidosis on ABG, which can be seen in larger or more severe PE

**2. Deep Vein Thrombosis (DVT)**

* Opposing findings:
	+ Absence of significant redness, warmth, or tenderness in the right lower leg, which are common symptoms of DVT
	+ No significant difference in calf circumference between the two legs, which can be seen in DVT
	+ Normal vital signs, which can be abnormal in DVT (e.g., tachycardia, fever)
* Expected but not present findings:
	+ More significant swelling or edema in the right lower leg, which can be seen in DVT
	+ Pain or tenderness in the right lower leg, which can be seen in DVT
	+ Elevated white blood cell count or erythrocyte sedimentation rate (ESR), which can be seen in DVT

**3. Postoperative Atelectasis or Pneumonia**

* Opposing findings:
	+ Chest CT angiogram showing a pulmonary embolism, which is not consistent with atelectasis or pneumonia
	+ Absence of fever, which is often seen in pneumonia
	+ No significant leukocytosis or elevated inflammatory markers, which can be seen in pneumonia
	+ Normal lung sounds on physical examination, except for decreased breath sounds at the right base
* Expected but not present findings:
	+ More significant hypoxemia or respiratory failure, which can be seen in atelectasis or pneumonia
	+ Elevated lactate dehydrogenase (LDH) or other biomarkers of lung injury, which can be seen in atelectasis or pneumonia
	+ Presence of consolidation or infiltrates on chest imaging, which can be seen in pneumonia

Note that the presence of a pulmonary embolism on chest CT angiogram makes postoperative atelectasis or pneumonia less likely, but it is still possible that the patient has a concurrent pulmonary complication.","Based on the patient's symptoms, physical examination, laboratory results, and imaging studies, the final diagnosis is:

**Acute Pulmonary Embolism (PE)**

The diagnosis is supported by:

* Sudden onset of shortness of breath and pleuritic chest pain
* Elevated D-dimer (8.5 µg/mL)
* Chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery
* Decreased breath sounds at the right base on physical examination
* Hypoxemia (pO2 70 mmHg) on ABG
* Recent hip replacement surgery, which increases the risk of venous thromboembolism (VTE)
* Immobility post-surgery, which increases the risk of VTE

The patient's symptoms and laboratory results are consistent with a pulmonary embolism, and the chest CT angiogram provides definitive evidence of the diagnosis. The patient's recent surgery and immobility are significant risk factors for developing a pulmonary embolism.

The patient will require immediate treatment with anticoagulation therapy, such as heparin or low-molecular-weight heparin, and possibly thrombolytic therapy if the patient is hemodynamically unstable. The patient will also require close monitoring and follow-up to prevent further complications and to manage any underlying conditions that may have contributed to the development of the pulmonary embolism.","Based on the final diagnosis of acute pulmonary embolism (PE), the following additional steps should be taken:

1. **Initiate anticoagulation therapy**: Start the patient on anticoagulation therapy with heparin or low-molecular-weight heparin to prevent further clot formation and extension of the existing clot.
2. **Order additional laboratory tests**: Order additional laboratory tests, such as:
	* Complete blood count (CBC) to rule out anemia or thrombocytopenia
	* Prothrombin time (PT) and activated partial thromboplastin time (aPTT) to monitor anticoagulation therapy
	* Liver function tests (LFTs) to monitor for potential liver injury
	* Troponin and BNP to assess for cardiac strain
3. **Perform a lower extremity ultrasound**: Perform a lower extremity ultrasound to evaluate for deep vein thrombosis (DVT) in the legs, which may be the source of the pulmonary embolism.
4. **Consult with a cardiologist or pulmonologist**: Consult with a cardiologist or pulmonologist to discuss the patient's management and treatment plan, including the possibility of thrombolytic therapy or other interventions.
5. **Monitor for complications**: Closely monitor the patient for complications of pulmonary embolism, such as:
	* Hypotension or shock
	* Cardiac arrest
	* Respiratory failure
	* Arrhythmias
6. **Develop a plan for long-term anticoagulation**: Develop a plan for long-term anticoagulation therapy, including the choice of anticoagulant, dosing, and duration of therapy.
7. **Consider thrombolytic therapy**: Consider thrombolytic therapy if the patient is hemodynamically unstable or has a high-risk pulmonary embolism.
8. **Order an ECG and echocardiogram**: Order an ECG and echocardiogram to assess for cardiac strain and to evaluate the patient's cardiac function.
9. **Provide patient education**: Provide patient education on the diagnosis, treatment, and management of pulmonary embolism, including the importance of anticoagulation therapy and follow-up care.
10. **Arrange for follow-up care**: Arrange for follow-up care with a primary care physician or a specialist to monitor the patient's condition and adjust the treatment plan as needed.

By taking these additional steps, the patient can receive comprehensive care and management for their pulmonary embolism, and the risk of complications and recurrence can be minimized.","{""Score"":3,""Rationale"":""Student listed Pulmonary Embolism, Deep Vein Thrombosis, and Pneumonia (as part of 'Postoperative Atelectasis or Pneumonia'), matching all three rubric items.""}","{""Score"":6,""Rationale"":""The answer includes all required concepts for each diagnosis: PE – sudden SOB, pleuritic chest pain, elevated D‑dimer, recent hip replacement, immobilization, and CT confirmation; Pneumonia – acknowledges cough/pleuritic pain but notes absence of fever and infection signs, making it less likely; DVT – mentions leg swelling, recent surgery, and links PE to a possible DVT source. All rubric points are met, earning full marks.""}","{""Score"":4,""Rationale"":""The answer includes opposing findings for DVT that match the rubric (no redness/warmth) and mentions absence of fever for pneumonia, which aligns with the rubric. However, for PE the rubric expects no opposing findings, whereas the student listed several opposing findings, so no points for PE. Total points awarded: 2 for DVT + 2 for pneumonia = 4.""}","{""Score"":2,""Rationale"":""The answer includes all key elements from the high‑scoring example: diagnosis of pulmonary embolism, sudden shortness of breath, pleuritic chest pain, elevated D‑dimer, and CT angiogram confirmation, thus meeting the rubric criteria for full credit.""}","{""Score"":4,""Rationale"":""The answer includes anticoagulation initiation and a lower extremity ultrasound for DVT evaluation, matching two rubric items (2 points each). It does not mention oxygen therapy, so no points for that item. Total score 4/6.""}",19.0
"History of Present Illness
A 74-year-old female presents with a 1-month history of progressive fatigue, dizziness, and pale appearance. Over the last two weeks, she has noticed intermittent black, tarry stools and occasional bright red blood after bowel movements. She denies significant abdominal pain, nausea, or vomiting but mentions a history of occasional heartburn, which she manages with over-the-counter antacids. She has no history of hemorrhoids or significant gastrointestinal issues. She does not recall recent weight loss, but reports feeling more fatigued than usual.

  Past Medical History
She has a history of hypertension, controlled with an angiotensin II receptor blocker, and osteoarthritis. She is a former smoker (quit 10 years ago) and consumes alcohol occasionally. No family history of gastrointestinal cancers or bleeding disorders.

  Physical Examination
VITALS: BP 110/70 mmHg, pulse 88 bpm, temperature 98.2°F. 
GEN: Pale and fatigued-appearing. 
CARDIAC: Regular rhythm, no murmurs. 
PULM: Clear to auscultation bilaterally. 
ABD: Mild epigastric tenderness, no hepatosplenomegaly. No rebound tenderness or guarding. 
EXT: No edema, peripheral pulses intact. 
SKIN: Pale conjunctiva, no jaundice.

  Laboratory Results
Hemoglobin: 8.9 g/dL (low). Hematocrit: 27% (low). Platelets: 150 x 10^3/μL. Fecal occult blood test: Positive. Colonoscopy: Findings of multiple diverticula with no active bleeding. No masses or polyps observed.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Diverticular disease with bleeding**: The patient's colonoscopy showed multiple diverticula, and her symptoms of black, tarry stools and bright red blood after bowel movements suggest gastrointestinal bleeding, which is a common complication of diverticular disease.
2. **Gastrointestinal malignancy**: Although the colonoscopy did not show any masses or polyps, it's possible that a malignancy is present in a location that was not visualized during the procedure, such as the small intestine or stomach. The patient's age and symptoms of fatigue, dizziness, and pale appearance also raise concern for a possible malignancy.
3. **Peptic ulcer disease**: The patient's history of occasional heartburn and use of antacids, combined with her symptoms of gastrointestinal bleeding, suggest the possibility of peptic ulcer disease. The mild epigastric tenderness on physical examination also supports this diagnosis. An upper endoscopy may be necessary to evaluate for ulcers in the stomach or duodenum.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Diverticular disease with bleeding**

* Colonoscopy findings of multiple diverticula
* Symptoms of black, tarry stools (melena) and bright red blood after bowel movements, which are consistent with gastrointestinal bleeding
* Age: Diverticular disease is more common in older adults, and the patient is 74 years old
* Lack of other obvious sources of bleeding on colonoscopy, making diverticular disease a more likely cause of the bleeding

**2. Gastrointestinal malignancy**

* Age: The patient is 74 years old, which puts her at higher risk for gastrointestinal malignancies
* Symptoms of progressive fatigue, dizziness, and pale appearance, which can be non-specific but may indicate anemia or other systemic effects of a malignancy
* Positive fecal occult blood test, which can be a sign of gastrointestinal bleeding or malignancy
* Although the colonoscopy did not show any masses or polyps, it's possible that a malignancy is present in a location that was not visualized, such as the small intestine or stomach

**3. Peptic ulcer disease**

* History of occasional heartburn and use of antacids, which suggests the patient may have gastroesophageal reflux disease (GERD) or other acid-related disorders that can increase the risk of peptic ulcers
* Symptoms of gastrointestinal bleeding, which is a common complication of peptic ulcers
* Mild epigastric tenderness on physical examination, which can be a sign of peptic ulcer disease
* Use of antacids may have masked symptoms of peptic ulcer disease, such as abdominal pain, but the patient's bleeding symptoms and anemia suggest that a more serious condition may be present.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Diverticular disease with bleeding**

* The colonoscopy did not show any active bleeding or signs of recent bleeding from the diverticula, which might have been expected if diverticular disease was the cause of the bleeding.
* The patient does not have a history of significant abdominal pain, which is often associated with diverticular disease.
* The patient's bleeding symptoms are intermittent, which is less typical of diverticular disease, where bleeding is often more sudden and severe.
* The lack of other signs of diverticulitis, such as fever, leukocytosis, or significant abdominal tenderness, makes diverticular disease with bleeding a less likely diagnosis.

**2. Gastrointestinal malignancy**

* The colonoscopy did not show any masses, polyps, or other lesions that are typically associated with gastrointestinal malignancies.
* The patient does not have a family history of gastrointestinal cancers or bleeding disorders, which might have increased her risk for a malignancy.
* The patient's symptoms of bleeding are relatively recent, and she does not have a history of weight loss, which is often a presenting symptom of gastrointestinal malignancies.
* The patient's laboratory results do not show any signs of liver dysfunction or other systemic effects that might be expected with a gastrointestinal malignancy.

**3. Peptic ulcer disease**

* The patient does not have a history of nonsteroidal anti-inflammatory drug (NSAID) use, which is a common risk factor for peptic ulcers.
* The patient's symptoms of bleeding are more typical of lower gastrointestinal bleeding (e.g., black, tarry stools), whereas peptic ulcers typically cause upper gastrointestinal bleeding (e.g., hematemesis).
* The patient's physical examination does not show any signs of peritonitis or other complications of peptic ulcer disease, such as rebound tenderness or guarding.
* The patient's laboratory results do not show any signs of liver dysfunction or other systemic effects that might be expected with a peptic ulcer, such as elevated liver enzymes or low albumin levels.","Based on the patient's presentation, laboratory results, and colonoscopy findings, the final diagnosis is:

**Diverticular disease with bleeding**

Although the colonoscopy did not show any active bleeding or signs of recent bleeding from the diverticula, the patient's symptoms of black, tarry stools and bright red blood after bowel movements, combined with the presence of multiple diverticula on colonoscopy, make diverticular disease with bleeding the most likely diagnosis.

The patient's age, lack of other obvious sources of bleeding on colonoscopy, and positive fecal occult blood test also support this diagnosis. Additionally, the patient's symptoms of fatigue, dizziness, and pale appearance are consistent with anemia, which is a common complication of diverticular disease with bleeding.

While the colonoscopy did not show any active bleeding, it's possible that the bleeding is intermittent and may have stopped by the time of the procedure. Further evaluation, such as a repeat colonoscopy or a tagged red blood cell scan, may be necessary to confirm the diagnosis and identify the source of bleeding.

Treatment for diverticular disease with bleeding typically involves supportive care, such as blood transfusions and iron supplements, as well as measures to control the bleeding, such as endoscopic therapy or angiographic embolization. The patient's underlying diverticular disease may also require treatment, such as fiber supplements and lifestyle modifications, to reduce the risk of future bleeding episodes.","Based on the final diagnosis of diverticular disease with bleeding, the following additional steps can be taken:

1. **Repeat colonoscopy**: To confirm the diagnosis and identify the source of bleeding, a repeat colonoscopy can be performed. This can help to visualize the diverticula and identify any signs of active bleeding or recent bleeding.
2. **Tagged red blood cell scan**: This is a nuclear medicine test that can help to identify the source of bleeding. A small amount of radioactive material is injected into the patient's bloodstream, and then a special camera is used to detect the radioactive material in the gastrointestinal tract.
3. **Upper endoscopy**: To rule out any other sources of bleeding, such as peptic ulcers or gastritis, an upper endoscopy can be performed.
4. **Blood transfusions**: To manage the patient's anemia, blood transfusions may be necessary.
5. **Iron supplements**: To replenish the patient's iron stores, iron supplements can be prescribed.
6. **Fiber supplements**: To help manage the patient's diverticular disease, fiber supplements can be prescribed to help soften stool and reduce the risk of future bleeding episodes.
7. **Follow-up appointments**: The patient should be scheduled for follow-up appointments to monitor their condition and adjust their treatment plan as needed.
8. **Consideration of angiographic embolization**: If the bleeding is severe and cannot be controlled with endoscopic therapy, angiographic embolization may be considered to control the bleeding.
9. **Evaluation for other potential causes of bleeding**: Although diverticular disease is the most likely cause of the patient's bleeding, other potential causes, such as gastrointestinal malignancies or vascular ectasias, should be evaluated and ruled out.
10. **Patient education**: The patient should be educated on the importance of following a high-fiber diet, staying hydrated, and avoiding straining during bowel movements to reduce the risk of future bleeding episodes.

By taking these additional steps, the patient's condition can be further evaluated and managed, and the risk of future bleeding episodes can be reduced.","{""Score"":2,""Rationale"":""The answer includes Peptic Ulcer Disease and Gastrointestinal Malignancy, which match two items in the rubric. However, it lists Diverticular disease instead of Gastritis with Chronic GI Bleeding, so only two of the three required concepts are present.""}","{""Score"":4,""Rationale"":""Student correctly identified Peptic Ulcer Disease with melena, heartburn/antacid use, and signs of anemia, matching the rubric (2 points). They did not mention Gastritis with chronic GI bleeding, so no points for that category (0 points). They identified Gastrointestinal Malignancy with anemia, positive fecal occult blood test, and lack of mass, aligning with the rubric (2 points). Total score is 4 out of 6.""}","{""Score"":4,""Rationale"":""Student identified and provided opposing findings for Peptic Ulcer Disease (no NSAID use) and Gastrointestinal Malignancy (no weight loss, no mass, normal colonoscopy), matching two rubric items (2 points each). They did not address Gastritis with Chronic GI Bleeding or mention lack of endoscopic confirmation, so no points for that item.""}","{""Score"":0,""Rationale"":""Student answer does not match any of the key concepts in the rubric (melena, anemia, positive fecal occult blood test, heartburn, and absence of lower GI bleeding supporting an upper GI source).""}","{""Score"":2,""Rationale"":""The answer includes performing an upper endoscopy, matching one rubric item. It does not mention starting PPI therapy, monitoring hemoglobin levels, or assessing/treating H. pylori, so only 2 of the possible 6 points are earned.""}",12.0
,,,,,,,,,,,,,,,,
